Screening strategies for atrial fibrillation: A systematic review and cost-effectiveness analysis

Health Technology Assessment

Volumn 21, Issue 29, 2017, Pages vii-235

  Welton, Nicky J ^a   McAleenan, Alexandra ^a   Thom, Howard H Z ^a   Davies, Philippa ^a   Hollingworth, Will ^a   Higgins, Julian P T ^a   Okoli, George ^a   Sterne, Jonathan A C ^a   Feder, Gene ^a   Eaton, Diane ^b   Hingorani, Aroon ^c   Fawsitt, Christopher ^a   Lobban, Trudie ^d,e   Bryden, Peter ^a   Richards, Alison ^a   Sofat, Reecha ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Anticoagulation Europe   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Atrial Fibrillation Association International   (United Kingdom)

^e Arrythmia Alliance   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ATRIAL FIBRILLATION; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLOOD PRESSURE MONITOR; BLOOD PRESSURE MONITORING; CLINICAL PRACTICE; CONSULTATION; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS; DATA EXTRACTION; DECISION TREE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECONOMIC EVALUATION; ECONOMIC MODEL; ELECTROCARDIOGRAPHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENERAL PRACTITIONER; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; MARKOV MODEL; NURSE PULSE PALPATION; PALPATION; PAROXYSMAL ATRIAL FIBRILLATION; PATIENT COMPLIANCE; PATIENT REFERRAL; PHOTOELECTRIC PLETHYSMOGRAPHY; POPULATION SIZE; PREDICTIVE VALUE; PREVALENCE; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCREENING TEST; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL MODEL; STUDY DESIGN; SYSTEMATIC ERROR; SYSTEMATIC OPPORTUNISTIC SCREENING; SYSTEMATIC POPULATION SCREENING; SYSTEMATIC REVIEW; AGED; BLOOD PRESSURE; ECONOMICS; FEMALE; MALE; MASS SCREENING; META ANALYSIS; PATIENT ATTITUDE; PRIMARY HEALTH CARE; PROCEDURES; PULSE RATE; QUALITY ADJUSTED LIFE YEAR; STANDARDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BLOOD PRESSURE; COST-BENEFIT ANALYSIS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MASS SCREENING; MODELS, ECONOMETRIC; PATIENT ACCEPTANCE OF HEALTH CARE; PRIMARY HEALTH CARE; PULSE; QUALITY-ADJUSTED LIFE YEARS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENSITIVITY AND SPECIFICITY;

EID: 85021271816     PISSN: 13665278     EISSN: 20464924     Source Type: Journal    
DOI: 10.3310/hta21290     Document Type: Review

References (422)

1. Public Health England. Atrial Fibrillation Prevalence Estimates in England: Application of Recent Population Estimates of AF in Sweden. London: Public Health England; 2015.
2. Norberg J, Bäckström S, Jansson JH, Johansson L. Estimating the prevalence of atrial fibrillation in a general population using validated electronic health data. Clin Epidemiol 2013;5:475–81.
3. Primary Care Domain, Health and Social Care Information Centre. Quality and Outcomes Framework – Prevalence, Achievements and Exceptions Report. England, 2014–15; 2015. URL: http://content.digital.nhs.uk/catalogue/PUB18887/qof-1415-Report%20vl.l.pdf
4. Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace 2013;15:486–93. http://dx.doi.org/10.1093/europace/eus333
5. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983–8. https://doi.org/10.1161/01.STR.22.8.983
6. Raju NC, Hankey GJ. Dabigatran etexilate in people with atrial fibrillation. BMJ 2010;341:c3784. http://dx.doi.org/10.1136/bmj.c3784
7. Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, D’Agostino RB. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996;27:1760–4. https://doi.org/10.1161/01.STR.27.10.1760
8. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012;366:120–9. http://dx.doi.org/10.1056/NEJMoa1105575
9. Vanassche T, Lauw MN, Eikelboom JW, Healey JS, Hart RG, Alings M, et al. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. Eur Heart J 2015;36:281–287a. http://dx.doi.org/10.1093/eurheartj/ehu307
10. Smolina K, Wright FL, Rayner M, Goldacre MJ. Incidence and 30-day case fatality for acute myocardial infarction in England in 2010: national-linked database study. Eur J Public Health 2012;22:848–53. http://dx.doi.org/10.1093/eurpub/ckr196
11. National Institute for Health and Care Excellence. Atrial Fibrillation: the Management of Atrial Fibrillation. Clinical guideline CG 180. London: NICE; 2014.
12. Canadian Agency for Drugs and Technologies in Health. Oral Anticoagulants in Nun-valvular Atrial Fibrillation: CADTH Recommendations and Clinical Practice Guidelines; 2016. URL: www.cadth.ca/oral-anticoagulants-non-valvular-atrial-fibrillation-cadth-recommendations-and-clinicalpractice (accessed 27 April 2017).
13. Kirchhof P, Benussi S, Koteeha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893–962. https://doi.org/10.1093/eur-heartj/ehw210
14. Nieuwlaat R, Prins MH, Le Heuzey JY, Vardas PE, Aliot E, Santini M, et al. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J 2008;29:1181–9. http://dx.doi.org/10.1093/eurheartj/ehn139
15. Lee S, Shafe AC, Cowie MR. UK stroke incidence, mortality and cardiovascular risk management 1999–2008: time-trend analysis from the General Practice Research Database. BMJ Open 2011;1:e000269. http://dx.doi.org/10.1136/bmjopen-2011-000269
16. Ben Freedman S, Lowres N. Asymptomatic atrial fibrillation: the case for screening to prevent stroke. JAMA 2015;314:1911–2. http://dx.doi.org/10.1001/jama.2015.9846
17. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 2010;137:263–72. http://dx.doi.org/10.1378/chest.09-1584
18. Lip GY. The CHA2DS2-VASc score for stroke risk stratification in patients with atrial fibrillation: a brief history. Eur Heart J 2015;36:2880–5. http://dx.doi.org/10.1093/eurheartj/ehv431
19. Hobbs FD, Fitzmaurice DA, Mant J, Murray E, Jowett S, Bryan S, et al. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess 2005;9(40). https://doi.org/10.3310/hta9400
20. Andrade JG, Field T, Khairy P. Detection of occult atrial fibrillation in patients with embolic stroke of uncertain source: a work in progress. Front Physiol 2015;6:100. http://dx.doi.org/10.3389/fphys.2015.00100
21. Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb Haemost 2014;111:1167–76. http://dx.doi.org/10.1160/TH14-03-0231
22. Engdahl J, Andersson L, Mirskaya M, Rosenqvist M. Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention. Circulation 2013;127:930–7. http://dx.doi.org/10.1161/CIRCULATIONAHA.112.126656
23. Wilson JMG, Jungner G. Principles and Practice of Screening for Disease. Geneva: WHO; 1968.
24. Allaby M. Screening for Atrial Fibrillation in People Aged 65 and Over. A Report for the National Screening Committee. Oxford: Solutions for Public Health; 2014.
25. Moran P, Teljeur C, Harrington P, Ryan M. Health Technology Assessment (HTA) of a National Screening Programme for Atrial Fibrillation in Primary Care: Health Information and Quality Authority; 2015. URL: www.hiqa.ie/sites/default/files/2017-02/HTA-of-screening-for-Atrial- Fibrillation.pdf
26. Friberg L, Engdahl J, Frykman V, Svennberg E, Levin LÅ, Rosenqvist M. Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP). Europace 2013;15:135–40. http://dx.doi.org/10.1093/europace/eus217
27. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946–52. https://doi.org/10.1161/01.CIR.98.10.946
28. Friberg L, Hammar N, Pettersson H, Rosenqvist M. Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF). Eur Heart J 2007;28:2346–53. https://doi.org/10.1093/eurheartj/ehm308
29. Hannon N, Sheehan O, Kelly L, Marnane M, Merwick A, Moore A, et al. Stroke associated with atrial fibrillation – incidence and early outcomes in the north Dublin population stroke study. Cerebrovasc Dis 2010;29:43–9. http://dx.doi.org/10.1159/000255973
30. Xie J, Wu EQ, Zheng ZJ, Croft JB, Greenlund KJ, Mensah GA, Labarthe DR. Impact of stroke on health-related quality of life in the noninstitutionalized population in the United States. Stroke 2006;37:2567–72. https://doi.org/10.1161/01.STR.0000240506.34616.10
31. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 2015;386:154–62. http://dx.doi.org/10.1016/S0140-6736(14)61774-8
32. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31:2369–429. https://doi.org/10.1093/eurheartj/ehq278
33. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74:236–41. https://doi.org/10.1016/0002-9149(94)90363-8
34. Savelieva I, Camm AJ. Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Interv Card Electrophysiol 2000;4:369–82. https://doi.org/10.1023/A:1009823001707
35. Flaker GC, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, et al. Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J 2005;149:657–63. https://doi.org/10.1016/j.ahj.2004.06.032
36. Mant J, Fitzmaurice DA, Hobbs FD, Jowett S, Murray ET, Holder R, et al. Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial. BMJ 2007;335:380. https://doi.org/10.1136/bmj.39227.551713.AE
37. Sterne J, Bodalia P, Bryden P, Davies P, Lopez-Lopez J, Okoli G, et al. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis. Health Technol Assess 2017;21(9).
38. Mant J, Hobbs FDR, Fletcher K, Roalfe A, Fitzmaurice D, Lip GYH, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007;370:493–503. https://doi.org/10.1016/S0140-6736(07)61233-1
39. NICE Implementation Collaborative. Supporting Local Implementation of NICE Guidance on Use of the Novel (Non-Vitamin K Antagonist) Oral Anticoagulants in Non-Valvular Atrial Fibrillation; 2014. URL: www.nice.org.uk/guidance/cg180/resources/nic-consensus-statement-on-the-use-of-noacs-243733501
40. Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M. Mass screening for untreated atrial fibrillation: the STROKESTOP study. Circulation 2015;131:2176–84. http://dx.doi.org/10.1161/CIRCULATIONAHA.114.014343
41. Lowres N, Neubeck L, Freedman SB. Can screening for atrial fibrillation be implemented at scale? Europace 2016;18:1449–51. https://doi.org/10.1093/europace/euw030
42. Christie B. People over 65 should be screened for atrial fibrillation, say stroke specialists. BMJ 2012;344:e1644. http://dx.doi.org/10.1136/bmj.e1644
43. Stott DJ, Dewar RI, Garratt W, Griffith KE, Harding NJ, James MA, et al. RCPE UK Consensus Conference on ‘Approaching the comprehensive management of atrial fibrillation: evolution or revolution?’. J R Coll Physicians Edinb 2012;42(Suppl 18):3–4. http://dx.doi.org/10.4997/JRCPE.2012.S01
44. Taggar JS, Coleman T, Lewis S, Jones M. Screening for atrial fibrillation – a cross-sectional survey of healthcare professionals in primary care. PLOS ONE 2016;11:e0152086. http://dx.doi.org/10.1371/journal.pone.0152086
45. National Institute for Health and Care Excellence. Patient Decision Aid. Atrila Fibrillation: Medicines to Help Reduce Your Risk of a Stroke – What are the Options? URL: www.nice.org.uk/guidance/cg180/resources/patient-decision-aid-243734797 (accessed 1 December 2016).
46. Man-Son-Hing M, Gage BF, Montgomery AA, Howitt A, Thomson R, Devereaux PJ, et al. Preference-based antithrombotic therapy in atrial fibrillation: implications for clinical decision making. Med Decis Making 2005;25:548–59. https://doi.org/10.1177/0272989X05280558
47. Thomson RG, Eccles MP, Steen IN, Greenaway J, Stobbart L, Murtagh MJ, May CR. A patient decision aid to support shared decision-making on anti-thrombotic treatment of patients with atrial fibrillation: randomised controlled trial. Qual Saf Health Care 2007;16:216–23. https://doi.org/10.1136/qshc.2006.018481
48. NICE. Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-ofcare coagulometers (ythe Coagu Check XS system and the INRatio2 PT/INR monitor); 2014. URL: www.nice.org.uk/guidance/dg14
49. Moran PS, Flattery MJ, Teljeur C, Ryan M, Smith SM. Effectiveness of systematic screening for the detection of atrial fibrillation. Cochrane Database Syst Rev 2013;4:CD009586. https://doi.org/10.1002/14651858.cd009586.pub2
50. Willis BH. Spectrum bias – why clinicians need to be cautious when applying diagnostic test studies. Fam Pract 2008;25:390–6. http://dx.doi.org/10.1093/fampra/cmn051
51. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529–36. http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00009
52. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 2005;58:882–93. https://doi.org/10.1016/j.jclinepi.2005.01.016
53. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 2001;20:2865–84. https://doi.org/10.1002/sim.942
54. Lunn D, Spiegelhalter D, Thomas A, Best N. The BUGS project: evolution, critique and future directions. Stat Med 2009;28:3049–67. https://doi.org/10.1002/sim.3680
55. Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A. Bayesian measures of model complexity and fit. J R Statist Soc B 2002;64:583–639. https://doi.org/10.1111/1467-9868.00353
56. Welton NJ. Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis. 2014. PROSPERO 2014:CRD42014013739. URL: www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014013739 (accessed 1 December 2016).
57. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995;155:469–73. https://doi.org/10.1001/archinte.1995.00430050045005
58. Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. http://dx.doi.org/10.1136/bmj.d5928
59. Effective Practice and Organisation of Care (EPOC). Summary assessments of the risk of bias. In EPOC Resources for Review Authors. Oslo: Norwegian Knowledge Centre for the Health Services; 2013.
60. Lee HO, Lee SJ, Jeong SH, Cho YH, Jang J, Kim DW, et al. A development and clinical evaluation of automated diagnostic algorithm for atrial fibrillation using 12-lead EKG. World Congress on Medical Physics and Biomedical Engineering 2006. In Kim SI, Suh TS, editors. IFMBE Proceedings, volume 14/1; 2007. pp. 1195–8.
61. Swancutt D, Hobbs R, Fitzmaurice D, Mant J, Murray E, Jowett S, et al. A randomised controlled trial and cost effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in the over 65s: (SAFE) [ISRCTN19633732]. BMC Cardiovasc Disord 2004;4:12. http://dx.doi.org/10.1186/1471-2261-4-12
62. Marazzi G, Iellamo F, Volterrani M, Lombardo M, Pelliccia F, Righi D, et al. Erratum to: Comparison of Microlife BP A200 Plus and Omron M6 blood pressure monitors to detect atrial fibrillation in hypertensive patients. Adv Ther 2014;31:1317. https://doi.org/10.1007/s12325-014-0172-2
63. Marazzi G, Iellamo F, Volterrani M, Lombardo M, Pelliccia F, Righi D, et al. Comparison of Microlife BP A200 Plus and Omron M6 blood pressure monitors to detect atrial fibrillation in hypertensive patients. Adv Ther 2012;29:64–70. http://dx.doi.org/10.1007/s12325-011-0087-0
64. Antonicelli R, Ripa C, Abbatecola AM, Capparuccia CA, Ferrara L, Spazzafumo L. Validation of the 3-lead tele-ECG versus the 12-lead tele-ECG and the conventional 12-lead ECG method in older people. J Telemed Telecare 2012;18:104–8. http://dx.doi.org/10.1258/jtt.2011.110613
65. Gregg RE, Zhou SH, Lindauer JM, Feild DQ, Helfenbein ED. Where do derived precordial leads fail? J Electrocardiol 2008;41:546–52. http://dx.doi.org/10.1016/j.jelectrocard.2008.07.018
66. Kaleschke G, Hoffmann B, Drewitz I, Steinbeck G, Naebauer M, Goette A, et al. Prospective, multicentre validation of a simple, patient-operated electrocardiographic system for the detection of arrhythmias and electrocardiographic changes. Europace 2009;11:1362–8. http://dx.doi.org/10.1093/europace/eup262
67. Kearley K, Selwood M, Van den Bruel A, Thompson M, Mant D, Hobbs FR, et al. Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors. BMJ Open 2014;4:e004565. http://dx.doi.org/10.1136/bmjopen-2013-004565
68. Langley P, Dewhurst M, Di Marco LY, Adams P, Dewhurst F, Mwita JC, et al. Accuracy of algorithms for detection of atrial fibrillation from short duration beat interval recordings. Med Eng Phys 2012;34:1441–7. http://dx.doi.org/10.1016/j.medengphy.2012.02.002
69. Lewis M, Parker D, Weston C, Bowes M. Screening for atrial fibrillation: sensitivity and specificity of a new methodology. Br J Gen Pract 2011;61:38–9. http://dx.doi.org/10.3399/bjgp11X548956
70. Somerville S, Somerville J, Croft P, Lewis M. Atrial fibrillation: a comparison of methods to identify cases in general practice. Br J Gen Pract 2000;50:727–9.
71. Stergiou GS, Karpettas N, Protogerou A, Nasothimiou EG, Kyriakidis M. Diagnostic accuracy of a home blood pressure monitor to detect atrial fibrillation. J Hum Hypertens 2009;23:654–8. http://dx.doi.org/10.1038/jhh.2009.5
72. Vaes B, Stalpaert S, Tavernier K, Thaels B, Lapeire D, Mullens W, Degryse J. The diagnostic accuracy of the MyDiagnostick to detect atrial fibrillation in primary care. BMC Fam Pract 2014;15:113. http://dx.doi.org/10.1186/1471-2296-15-113
73. Slocum J, Sahakian A, Swiryn S. Diagnosis of atrial fibrillation from surface electrocardiograms based on computer-detected atrial activity. J Electrocardiol 1992;25:1–8. https://doi.org/10.1016/0022-0736(92)90123-H
74. Lau JK, Lowres N, Neubeck L, Brieger DB, Sy RW, Galloway CD, et al. iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. Int J Cardiol 2013;165:193–4. http://dx.doi.org/10.1016/j.ijcard.2013.01.220
75. Harris K, Edwards D, Mant J. How can we best detect atrial fibrillation? J R Coll Physicians Edinb 2012;42(Suppl 18):5–22. http://dx.doi.org/10.4997/JRCPE.2012.S02
76. National Institute for Health and Care Excellence. WatchBP Home A for Opportunistically Detecting Atrial Fibrillation during Diagnosis and Monitoring of Hypertension. Medical technologies guidance (MTG13). London: NICE; 2013.
77. Taggar JS, Coleman T, Lewis S, Heneghan C, Jones M. Accuracy of methods for detecting an irregular pulse and suspected atrial fibrillation: a systematic review and meta-analysis. Eur J Prev Cardiol 2016;23:1330–8. http://dx.doi.org/10.1177/2047487315611347
78. Taggar JS, Coleman T, Lewis S, Heneghan C, Jones M. Accuracy of methods for diagnosing atrial fibrillation using 12-lead ECG: a systematic review and meta-analysis. Int J Cardiol 2015;184:175–83. http://dx.doi.org/10.1016/j.ijcard.2015.02.014
79. Kane SA, Blake JR, McArdle FJ, Langley P, Sims AJ. Opportunistic detection of atrial fibrillation using blood pressure monitors: a systematic review. Open Heart 2016;3:e000362. http://dx.doi.org/10.1136/openhrt-2015-000362
80. Verberk WJ, Omboni S, Kollias A, Stergiou GS. Screening for atrial fibrillation with automated blood pressure measurement: research evidence and practice recommendations. Int J Cardiol 2016;203:465–73. http://dx.doi.org/10.1016/j.ijcard.2015.10.182
81. Pérula-de-Torres LA, Martinez-Adell MÁ, González-Blanco V, Baena-Diez JM, Martin-Rioboó E, Parras-Rejano JM, et al. Opportunistic detection of atrial fibrillation in subjects aged 65 years or older in primare care: a randomised clinical trial of efficacy. DOFA-AP study protocol. BMC Fam Pract 2012;13:106. https://doi.org/10.1186/1471-2296-13-106
82. Morgan S, Mant D. Randomised trial of two approaches to screening for atrial fibrillation in UK general practice. Br J Gen Pract 2002;52:373–374, 377–80.
83. Benito L, Coll-Vinent B, Gómez E, Martí D, Mitjavila J, Torres F, et al. EARLY: a pilot study on early diagnosis of atrial fibrillation in a primary healthcare centre. Europace 2015;17:1688–93. http://dx.doi.org/10.1093/europace/euv146
84. Fitzmaurice DA, Hobbs FD, Jowett S, Mant J, Murray ET, Holder R, et al. Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial. BMJ 2007;335:383. https://doi.org/10.1136/bmj.39280.660567.55
85. ClinicalTrials.gov. Improving DEtection of Atrial fibriLlation in primary care with the MyDiagnostick (IDEAL-MD). 4 September 2014. URL: https://clinicaltrials.gov/ct2/show/NCT02270151(accessed 16 January 2017).
86. Uittenbogaart SB, Verbiest-van Gurp N, Erkens PM, Lucassen WA, Knottnerus JA, Winkens B, et al. Detecting and Diagnosing Atrial Fibrillation (D2AF): study protocol for a cluster randomised controlled trial. Trials 2015;16:478. https://doi.org/10.1186/s13063-015-1006-5
87. Tucker J, Consumer Price Inflation time series dataset (MM23); 2017. URL: www.ons.gov.uk/ economy/inflationandpriceindices/timeseries/chaw/mm23
88. EuroQol Group. EQ-5D. URL: www.euroqol.org
89. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State–Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992;31:301–6. http://dx.doi.org/10.1111/j.2044-8260.1992.tb00997.x
90. Lowres N, Neubeck L, Redfern J, Freedman SB. Screening to identify unknown atrial fibrillation. A systematic review. Thromb Haemost 2013;110:213–22. http://dx.doi.org/10.1160/TH13-02-0165
91. Briggs AH, Sculpher M, Claxton K. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press; 2006.
92. National Institute for Health and Care Excellence. Guide to the Methods of Technology Appraisal 2013. URL: www.nice.org.uk/process/pmg9/chapter/foreword (accessed 1 December 2016).
93. HM Treasury. The Green Book: Appraisal and Evaluation in Central Government. London: TSO; 2003.
94. Lavenson GS, Pantera RL, Garza RM, Neff T, Rothwell SD, Cisneros J. Development and implementation of a rapid, accurate, and cost-effective protocol for national stroke prevention screening. Am J Surg 2004;188:638–43. https://doi.org/10.1016/j.amjsurg.2004.08.055
95. McClennen S, Zimetbaum PJ, Ho KK, Goldberger AL. Holter monitoring: are two days better than one? Am J Cardiol 2000;86:562–564, A9.
96. Maeda K, Shimbo T, Fukui T. Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan. J Med Screen 2004;11:97–102. http://dx.doi.org/10.1258/096914104774061092
97. Levin LÅ, Husberg M, Sobocinski PD, Kull VF, Friberg L, Rosenqvist M, Davidson T. A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke. Europace 2015;17:207–14. http://dx.doi.org/10.1093/europace/euu213
98. Centre for Reviews and Dissemination. ISSG Search Filters Resource. Filters to Identify Economic Evaluations. URL: https://sites.google.com/a/york.ac.uk/issg-search-filters-resource/filters-to-find-i (accessed 11 June 2016).
99. Aronsson M, Levin L. Finding the optimal screening program for unknown atrial fibrillation using simulation models. Value Health 2015;18:A354. http://dx.doi.org/10.1016/j.jval.2015.09.658
100. Aronsson M, Svennberg E, Rosenqvist M, Engdahl J, Al-Khalili F, Friberg L, et al. Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording. Europace 2015;17:1023–9. http://dx.doi.org/10.1093/europace/euv083
101. Diamantopoulos A, Sawyer L, Sungher D, Lip G, Witte K, Reynolds MR, et al. Use of an insertable cardiac monitor to detect atrial fibrillation is cost effective in patients with cryptogenic stroke. Stroke 2015;46:A14.
102. Limone BL, Baker WL, Mearns ES, White CM, Kluger J, Coleman CI. Common flaws exist in published cost-effectiveness models of pharmacologic stroke prevention in atrial fibrillation. J Clin Epidemiol 2014;67:1093–102. http://dx.doi.org/10.1016/j.jclinepi.2014.05.013
103. Lorenzoni G, Folino F, Soriani N, Iliceto S, Gregori D. Cost-effectiveness of early detection of atrial fibrillation via remote control of implanted devices. J Eval Clin Pract 2014;20:570–7. http://dx.doi.org/10.1111/jep.12132
104. Lowres N, Neubeck L, Redfern J, McLachlan A, Krass I, Bennett A, et al. Screening Education And Recognition in Community pHarmacies of Atrial Fibrillation to prevent stroke (SEARCH-AF stroke prevention study). Heart Lung Circ 2013;22:S223. https://doi.org/10.1016/j.hlc.2013.05.532
105. Moran P, Teljeur C, Harrington P, Smith S, Normand C, Ryan M. Opportunistic screening for atrial fibrillation in primary care – a clinical and cost-effectiveness analysis. Value Health 2015;18:A391. http://dx.doi.org/10.1016/j.jval.2015.09.868
106. Willits I, Keltie K, Craig J, Sims A. WatchBP Home A for opportunistically detecting atrial fibrillation during diagnosis and monitoring of hypertension: a NICE medical technology guidance. Appl Health Econ Health Policy 2014;12:255–65. https://doi.org/10.1007/s40258-014-0096-7
107. Becker C. Cost-of-illness studies of atrial fibrillation: methodological considerations. Expert Rev Pharmacoecon Outcomes Res 2014;14:661–84. http://dx.doi.org/10.1586/14737167.2014.940904
108. Fak AS, Küçükoğlu MS, Fak NA, Demir M, Ağir AA, Demirtas¸ M, et al. Expert panel on cost analysis of atrial fibrillation. Anadolu Kardiyol Derg 2013;13:26–38. http://dx.doi.org/10.5152/akd.2013.004
109. Turakhia MP, Shafrin J, Bognar K, Goldman DP, Mendys PM, Abdulsattar Y, et al. Economic burden of undiagnosed nonvalvular atrial fibrillation in the United States. Am J Cardiol 2015;116:733–9. http://dx.doi.org/10.1016/j.amjcard.2015.05.045
110. Kassianos G, Arden C, Hogan S, Baldock L, Fuat A. The non-anticoagulation costs of atrial fibrillation management: findings from an observational study in NHS primary care. Drugs Context 2014;3:212254. http://dx.doi.org/10.7573/dic.212254
111. Mayer F, Stahrenberg R, Gröschel K, Mostardt S, Biermann J, Edelmann F, et al. Cost-effectiveness of 7-day-Holter monitoring alone or in combination with transthoracic echocardiography in patients with cerebral ischemia. Clin Res Cardiol 2013;102:875–84. http://dx.doi.org/10.1007/s00392-013-0601-2
112. Krummen DE, Patel M, Nguyen H, Ho G, Kazi DS, Clopton P, et al. Accurate ECG diagnosis of atrial tachyarrhythmias using quantitative analysis: a prospective diagnostic and cost-effectiveness study. J Cardiovasc Electrophysiol 2010;21:1251–9. http://dx.doi.org/10.1111/j.1540-8167.2010.01809.x
113. Suter D, Saczynski J, Floyd K, Browning C, Rosenthal L, McManus D. Quality of life in symptomatic patients with atrial fibrillation: preliminary data from the InRhythm study. Crit Path Cardiol 2014;13:128–9.
114. Zhang L, Gallagher R, Neubeck L. Health-related quality of life in atrial fibrillation patients over 65 years: a review. Eur J Prev Cardiol 2015;22:987–1002. http://dx.doi.org/10.1177/2047487314538855
115. Grönefeld GC, Lilienthal J, Kuck K-H, Hohnloser S, Pharmacological Intervention in Atrial Fibrillation (PIAF) study investigators. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study. Eur Heart J 2003;24:1430–6. https://doi.org/10.1016/S0195-668X(03)00261-6
116. Lord J, Willis S, Eatock J, Tappenden P, Trapero-Bertran M, Miners A, et al. Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project. Health Technol Assess 2013;17(58). http://dx.doi.org/10.3310/hta17580
117. Rhys GC, Azhar MF, Foster A. Screening for atrial fibrillation in patients aged 65 years or over attending annual flu vaccination clinics at a single general practice. Qual Prim Care 2013;21:131–40.
118. Gordon S, Hickman M, Pentney V. Screening for asymptomatic atrial fibrillation at seasonal influenza vaccination. Primary Care Cardiovasc J 2012;5:161–4.
119. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) – explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health 2013;16:231–50. http://dx.doi.org/10.1016/j.jval.2013.02.002
120. Trinity College Dublin. The Irish Longitudinal Study on Ageing (TILDA). 2017. URL: http://tilda.tcd.ie/
121. National Institute for Health and Care Excellence. Atrial Fibrillation: The Management of Atrial Fibrillation (CG36). 2006. URL: www.nice.org.uk/guidance/cg36
122. Department of Health. NHS Reference Costs 2014–15. London: Department of Health; 2014.
123. Curtis L, Burns A. Unit Costs of Health and Social Care 2015. Canterbury: PSSRU, University of Kent; 2015.
124. Xiong Q, Proietti M, Senoo K, Lip GY. Asymptomatic versus symptomatic atrial fibrillation: a systematic review of age/gender differences and cardiovascular outcomes. Int J Cardiol 2015;191:172–7. http://dx.doi.org/10.1016/j.ijcard.2015.05.011
125. Schnabel RB, Wilde S, Wild PS, Munzel T, Blankenberg S. Atrial fibrillation: its prevalence and risk factor profile in the German general population. Dtsch Arztebl Int 2012;109:293–9. http://dx.doi.org/10.3238/arztebl.2012.0293
126. Frewen J, Finucane C, Cronin H, Rice C, Kearney PM, Harbison J, Kenny RA. Factors that influence awareness and treatment of atrial fibrillation in older adults. QJM 2013;106:415–24. http://dx.doi.org/10.1093/qjmed/hct060
127. Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J 2013;34:2746–51. http://dx.doi.org/10.1093/eurheartj/eht280
128. Gómez-Doblas JJ, Muñiz J, Martin JJ, Rodríguez-Roca G, Lobos JM, Awamleh P, et al. Prevalence of atrial fibrillation in Spain. OFRECE study results. Rev Esp Cardiol 2014;67:259–69. http://dx.doi.org/10.1016/j.rec.2013.07.014
129. Baena-Díez JM, Grau M, Forés R, Fernández-Bergés D, Elosua R, Sorribes M, et al. Prevalence of atrial fibrillation and its associated factors in Spain: an analysis of 6 population-based studies. DARIOS Study. Rev Clin Esp 2014;214:505–12. http://dx.doi.org/10.1016/j.rce.2014.06.006
130. Office for National Statistics. Statistical Bulletin: Annual Mid-Year Population Estimates: 2014. 2015. URL: www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/ populationestimates/bulletins/annualmidyearpopulationestimates/2015-06-25 (accessed 16 January 2017).
131. Davis RC, Hobbs FD, Kenkre JE, Roalfe AK, Iles R, Lip GY, Davies MK. Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study. Europace 2012;14:1553–9. http://dx.doi.org/10.1093/europace/eus087
132. Bury G, Swan D, Cullen W, Keane D, Tobin H, Egan M, et al. Screening for atrial fibrillation in general practice: a national, cross-sectional study of an innovative technology. Int J Cardiol 2015;178:247–52. http://dx.doi.org/10.1016/j.ijcard.2014.10.037
133. Kesselheim AS, Cresswell K, Phansalkar S, Bates DW, Sheikh A. Clinical decision support systems could be modified to reduce ‘alert fatigue’ while still minimizing the risk of litigation. Health Aff 2011;30:2310–17. http://dx.doi.org/10.1377/hlthaff.2010.1111
134. Claes N, Van Laethem C, Goethals M, Goethals P, Mairesse G, Schwagten B, et al. Prevalence of atrial fibrillation in adults participating in a large-scale voluntary screening programme in Belgium. Acta Cardiol 2012;67:273–8. http://dx.doi.org/10.2143/AC.67.3.2160714
135. Kaasenbrood F, Hollander M, Rutten FH, Gerhards LJ, Hoes AW, Tieleman RG. Yield of screening for atrial fibrillation in primary care with a hand-held, single-lead electrocardiogram device during influenza vaccination. Europace 2016;18:1514–20. https://doi.org/10.1093/europace/euv426
136. Deif B, Lowres N, Freedman SB. Screening for atrial fibrillation above age 65 detects an asymptomatic subset at high risk of stroke. Int J Cardiol 2013;164:371–2. http://dx.doi.org/10.1016/j.ijcard.2012.08.002
137. Panisello-Tafalla A, Clua-Espuny JL, Gil-Guillen VF, González-Henares A, Queralt-Tomas ML, López-Pablo C, et al. Results from the Registry of Atrial Fibrillation (AFABE): gap between undiagnosed and registered atrial fibrillation in adults – ineffectiveness of oral anticoagulation treatment with VKA. Biomed Res Int 2015;2015:134756. http://dx.doi.org/10.1155/2015/134756
138. Sanmartín M, Fraguela Fraga F, Martín-Santos A, Moix Blázquez P, García-Ruiz A, Vázquez-Caamaño M, Vilar M, Grupo RIA (Registros en Insuficiencia Cardiaca y Aterosclerosis). A campaign for information and diagnosis of atrial fibrillation: ‘pulse week’. Rev Esp Cardiol 2013;66:34–8. http://dx.doi.org/10.1016/j.recesp.2012.05.012
139. Smyth B, Marsden P, Corcoran R, Walsh R, Brennan C, McSharry K, et al. Opportunistic screening for atrial fibrillation in a rural area. QJM 2016;109:539–43. http://dx.doi.org/10.1093/qjmed/hcw011
140. Rienstra M, Vermond RA, Crijns HJ, Tijssen JG, Van Gelder IC, RACE Investigators. Asymptomatic persistent atrial fibrillation and outcome: results of the RACE study. Heart Rhythm 2014;11:939–45. http://dx.doi.org/10.1016/j.hrthm.2014.03.016
141. Frykman V, Frick M, Jensen-Urstad M, Ostergren J, Rosenqvist M. Asymptomatic versus symptomatic persistent atrial fibrillation: clinical and noninvasive characteristics. J Intern Med 2001;250:390–7. https://doi.org/10.1046/j.1365-2796.2001.00893.x
142. Senoo K, Suzuki S, Otsuka T, Sagara K, Matsuno S, Kano H, et al. Progression to the persistent form in asymptomatic paroxysmal atrial fibrillation. Circ J 2014;78:1121–6. https://doi.org/10.1253/circj.CJ-13-1272
143. Ruigómez A, Johansson S, Wallander MA, García Rodríguez LA. Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK. BMC Cardiovasc Disord 2005;5:20. https://doi.org/10.1186/1471-2261-5-20
144. Holmqvist F, Kim S, Steinberg BA, Reiffel JA, Mahaffey KW, Gersh BJ, et al. Heart rate is associated with progression of atrial fibrillation, independent of rhythm. Heart 2015;101:894–9. http://dx.doi.org/10.1136/heartjnl-2014-307043
145. Kato T, Yamashita T, Sagara K, Iinuma H, Fu LT. Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study. Circ J 2004;68:568–72. https://doi.org/10.1253/circj.68.568
146. Al-Khatib SM, Wilkinson WE, Sanders LL, McCarthy EA, Pritchett EL. Observations on the transition from intermittent to permanent atrial fibrillation. Am Heart J 2000;140:142–5. https://doi.org/10.1067/mhj.2000.107547
147. Steinberg BA, Hellkamp AS, Lokhnygina Y, Patel MR, Breithardt G, Hankey GJ, et al. Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF trial. Eur Heart J 2015;36:288–96. http://dx.doi.org/10.1093/europace/euv390
148. Friberg L, Hammar N, Rosenqvist M. Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. Eur Heart J 2010;31:967–75. http://dx.doi.org/10.1093/eurheartj/ehn599
149. Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ, ACTIVE W Investigators. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W substudy. J Am Coll Cardiol 2007;50:2156–61. https://doi.org/10.1016/j.jacc.2007.07.076
150. Martinez C, Katholing A, Freedman SB. Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study. Thromb Haemost 2014;112:276–86. http://dx.doi.org/10.1160/TH4-04-0383
151. Avgil Tsadok M, Jackevicius CA, Rahme E, Humphries KH, Behlouli H, Pilote L. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. JAMA 2012;307:1952–8. http://dx.doi.org/10.1001/jama.2012.3490
152. Kerr CR, Humphries KH, Talajic M, Klein GJ, Connolly SJ, Green M, et al. Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J 2005;149:489–96. https://doi.org/10.1016/j.ahj.2004.09.053
153. Fitzmaurice DA, McCahon D, Baker J, Murray ET, Jowett S, Sandhar H, et al. Is screening for AF worthwhile? Stroke risk in a screened population from the SAFE study. Fam Pract 2014;31:298–302. http://dx.doi.org/10.1093/fampra/cmu011
154. Cowan C, Healicon R, Robson I, Long WR, Barrett J, Fay M, et al. The use of anticoagulants in the management of atrial fibrillation among general practices in England. Heart 2013;99:1166–72. http://dx.doi.org/10.1136/heartjnl-2012-303472
155. Apenteng PN, Murray ET, Hobbs FDR, Kakkar AK, Fitzmaurice DA. Patterns of antithrombotic therapy in relation to type of atrial fibrillation: insights from the UK cohort of the global GARFIELD registry. Europace 2014;16:314. https://doi.org/10.1093/europace/euu239.3
156. Faria R, Walker S, Whyte S, Dixon S, Palmer S, Sculpher M. How to invest in getting cost-effective technologies into practice? A framework for value of implementation analysis applied to novel oral anticoagulants. Med Decis Making 2016;37:148–61. https://doi.org/10.1177/0272989X16645577
157. Office for National Statistics. ONS Consumer Price Inflation Index for Medical Services (DKC3) for 2016 (released 17 May 2016). URL: www.ons.gov.uk/economy/inflationandpriceindices/timeseries/dkc3 (accessed 20 May 2016).
158. Kansal AR, Sorensen SV, Gani R, Robinson P, Pan F, Plumb JM, Cowie MR. Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation. Heart 2012;98:573–8. http://dx.doi.org/10.1136/heartjnl-2011-300646
159. Bayer Plc. Single Technology Appraisal (STA) of Rivaroxaban (Xarelto); 2011. URL: www.nice.org.uk/guidance/ta256/documents/atrial-fibrillation-stroke-prevention-rivaroxaban-buyer4
160. Wells G, Coyle D, Cameron C, Steiner S, Coyle K, Kelly S, et al. Safety, Effectiveness, and Cost-effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events In Patients with Atrial Fibrillation. Canada: Canadian Agency for Drugs and Technologies in Health (CADTH). Therapeutic Review 2012. URL: http://cadth.ca/media/pdf/NOAC_Therapeutic_Review_final_report.pdf (accessed 16 January 2017).
161. Aguilar MI, Hart R, Pearce LA. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 2007;3:CD006186. https://doi.org/10.1002/14651858.cd006186.pub2
162. Friberg L, Rosenqvist M, Lip GY. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J 2012;33:1500–10. http://dx.doi.org/10.1093/eurheartj/ehr488
163. Andersen KK, Olsen TS. Reduced poststroke mortality in patients with stroke and atrial fibrillation treated with anticoagulants: results from a Danish quality-control registry of 22,179 patients with ischemic stroke. Stroke 2007;38:259–63. https://doi.org/10.1161/01.STR.0000254622.52483.03
164. Joint Formulary Committee. British National Formulary. 69th ed. London: BMJ Group and Pharmaceutical Press; 2015.
165. Department of Health. NHS Reference Costs 2013–14. London: Department of Health; 2014.
166. Luengo-Fernandez R, Yiin GS, Gray AM, Rothwell PM. Population-based study of acute- and long-term care costs after stroke in patients with AF. Int J Stroke 2013;8:308–14. http://dx.doi.org/10.1111/j.1747-4949.2012.00812.x
167. Scottish Centre for Telehealth and Telecare. Atrial Fibrillation. URL: www.sctt.scot.nhs.uk/programmes/health/cardiac/atrial-fibrillation/ (accessed 16 June 2016).
168. Health and Social Care Information Centre. Numbers of Patients Registered at a GP Practice – April 2016. URL: www.hscic.gov.uk/article/2021/Website-Search?productid=16843 (accessed 15 June 2016).
169. Wolff A, Long S, McComb J, Richley D, Mercer P. The gap between training and provision: a primary-care based ECG survey in North-East England. Br J Cardiol 2012;19:38–40. https://doi.org/10.5837/bjc.2012.008
170. Numed Healthcare. 12 Lead ECG Machines. URL: www.numed.co.uk/products/category/12-lead-ecg (accessed 15 June 2016).
171. Bonanzamarket. URL: www.bonanzamarket.co.uk/listings/OLED-Pulse-Finger-Fingertip-Oximeter-Blood-SpO2-PR-Heart-Rate-Monitor/352640758?goog_pla=1&variation_id=125007605&gpid=18283950120&keyword=&goog_pla=1&pos=1o10&ad_type=pla&gclid=CKjuoLSmqM0CFQkq0wodnFMPBA (accessed 15 June 2016).
172. Omron. Omron M6 Comfort Upper Arm Blood Pressure Monitor. URL: http://omronwebshop.co.uk/blood-pressure-monitors/upper-arm-blood-pressure-monitors/new-m6-comfort.html (accessed 15 June 2016).
173. Wright J, Bibby J, Eastham J, Harrison S, McGeorge M, Patterson C, et al. Multifaceted implementation of stroke prevention guidelines in primary care: cluster-randomised evaluation of clinical and cost effectiveness. Qual Saf Health Care 2007;16:51–9. https://doi.org/10.1136/qshc.2006.019778
174. Caley M, Chohan P, Hooper J, Wright N. The impact of NHS Health Checks on the prevalence of disease in general practices: a controlled study. Br J Gen Pract 2014;64:e516–21. http://dx.doi.org/10.3399/bjgp14X681013
175. Abe R, Nishida T. [The criteria for the prediction of paroxysmal atrial fibrillation by time domain analysis of the P wave-triggered signal-averaged electrocardiogram.] Nippon Rinsho 1995;53:496–502.
176. Albilali A, Gulamhusein S, Butcher K, Khera S, Kivi P, Abassi M, et al. Occult atrial fibrillation detected by auto-triggered loop recorder screening in a community-based population (a result of the first 40 participants). Int J Stroke 2014;9:194.
177. Al-Fahoum AS, Qasaimeh AM. A practical reconstructed phase space approach for ECG arrhythmias classification. J Med Eng Technol 2013;37:401–8. http://dx.doi.org/10.3109/03091902.2013.819946
178. Alis C, del Rosario C, Buenaobra B, Mar Blanca C. Lifelink: 3G-based mobile telemedicine system. Telemed J E Health 2009;15:241–7. http://dx.doi.org/10.1089/tmj.2008.0098
179. Amir O, Barak-Shinar D, Wolff R, Amos Y, Paz H, Smart F, et al. Atrial fibrillation detection using a photoplethysmograph waveform. Sleep 2011;34:A234.
180. Andrikopoulos GK, Dilaveris PE, Richter DJ, Gialafos EJ, Synetos AG, Gialafos JE. Increased variance of P wave duration on the electrocardiogram distinguishes patients with idiopathic paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000;23:1127–32. https://doi.org/10.1111/j.1540-8159.2000.tb00913.x
181. Anh D, Krishnan S, Bogun F. Accuracy of electrocardiogram interpretation by cardiologists in the setting of incorrect computer analysis. J Electrocardiol 2006;39:343–5. https://doi.org/10.1016/j.jelectrocard.2006.02.002
182. Aras D, Maden O, Ozdemir O, Aras S, Topaloglu S, Yetkin E, et al. Simple electrocardiographic markers for the prediction of paroxysmal atrial fibrillation in hyperthyroidism. Int J Cardiol 2005;99:59–64. https://doi.org/10.1016/j.ijcard.2003.11.040
183. Asl BM, Setarehdan SK, Mohebbi M. Support vector machine-based arrhythmia classification using reduced features of heart rate variability signal. Artif Intell Med 2008;44:51–64. http://dx.doi.org/10.1016/j.artmed.2008.04.007
184. Aytemir K, Aksoyek S, Ozer N, Aslamaci S, Oto A. Atrial fibrillation after coronary artery bypass surgery: P wave signal averaged ECG, clinical and angiographic variables in risk assessment. Int J Cardiol 1999;69:49–56. https://doi.org/10.1016/S0167-5273(99)00005-4
185. Aytemir K, Ozer N, Atalar E, Sade E, Aksöyek S, Ovünç K, et al. P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000;23:1109–12. https://doi.org/10.1111/j.1540-8159.2000.tb00910.x
186. Babaeizadeh S, Gregg RE, Helfenbein ED, Lindauer JM, Zhou SH. Improvements in atrial fibrillation detection for real-time monitoring. J Electrocardiol 2009;42:522–6. http://dx.doi.org/10.1016/j.jelectrocard.2009.06.006
187. Bae MH, Lee JH, Lee HS, Yang DH, Park HS, Cho Y, et al. Common errors in automatic computer ECG interpretation of atrial fibrillation. Europace 2011;13:167.
188. Bae MH, Lee JH, Yang DH, Park HS, Cho Y, Chae SC, Jun JE. Erroneous computer electrocardiogram interpretation of atrial fibrillation and its clinical consequences. Clin Cardiol 2012;35:348–53. http://dx.doi.org/10.1002/clc.22000
189. Bansil S, Karim H. Detection of atrial fibrillation in patients with acute stroke. J Stroke Cerebrovasc Dis 2004;13:12–15. https://doi.org/10.1016/j.jstrokecerebrovasdis.2004.01.004
190. Barrett P, Komatireddy R, Topol EJ. Comparison of a novel 14-day adhesive continuous ECG monitoring patch to traditional 24-hour Holter monitoring in symptomatic arrhythmia patients. Irish J Med Sci 2013;182:S374.
191. Barrett PM, Komatireddy R, Haaser S, Topol S, Sheard J, Encinas J, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med 2014;127:95.e11–95.e17. https://doi.org/10.1016/j.amjmed.2013.10.003
192. Barthélémy JC, Féasson-Gérard S, Garnier P, Gaspoz JM, Da Costa A, Michel D, Roche F. Automatic cardiac event recorders reveal paroxysmal atrial fibrillation after unexplained strokes or transient ischemic attacks. Ann Noninvasive Electrocardiol 2003;8:194–9. https://doi.org/10.1046/j.1542-474X.2003.08305.x
193. Benavente L, Calleja S, Vega J, Larrosa D, Rico M, Para M, et al. Yield of Holter and echocardiography in the screening of TIA. Cerebrovasc Dis 2013;35:490.
194. Bernard P, Chaitman BR, Scholl JM, Chabot M. [Value of the automated analysis of the electrocardiogram by the Telemed program (V version).] Arch Mal Coeur Vaiss 1981;74:1155–62.
195. Boudaoud S, Rix H, Blanc JJ, Cornily JC, Meste O. Integrated shape averaging of the P-wave applied to AF risk detection. Comput Cardiol 2003;30:125–8. https://doi.org/10.1109/cic.2003.1291106
196. Bourdillon PJ, Kilpatrick D. Clinicians, the Mount Sinai program and the Veterans’ Administration program evaluated against clinico-pathological data derived independently of the electrocardiogram. Eur J Cardiol 1978;8:395–412.
197. Boyle KO, Morra D, Dorian P, McCrorie A, Haddad P, Taylor L, et al. Atrial fibrillation screening using a handheld ECG device: results from the Heart and Stroke Foundation (HSF) ‘be pulse aware’ campaign. Stroke 2013;44:e184.
198. Budeus M, Hennersdorf M, Perings C, Strauer BE. Detection of atrial late potentials with P wave signal averaged electrocardiogram among patients with paroxysmal atrial fibrillation. Z Kardiol 2003;92:362–9. https://doi.org/10.1007/s00392-003-0921-8
199. Budeus M, Hennersdorf M, Wieneke H, Sack S, Erbel R, Perings C. P wave signal averaged ECG and chemoreflexsensitivity in paroxysmal atrial fibrillation. Int J Cardiol 2005;100:317–24. https://doi.org/10.1016/j.ijcard.2004.12.001
200. Caldwell JC, Borbas Z, Donald A, Clifford A, Bolger L, Black A, et al. Simplified electrocardiogram sampling maintains high diagnostic capability for atrial fibrillation: implications for opportunistic atrial fibrillation screening in primary care. Europace 2012;14:191–6. http://dx.doi.org/10.1093/europace/eur304
201. Chao TF, Sung SH, Wang KL, Tsao HM, Lin YJ, Chang SL, et al. Atrial electromechanical interval can identify patients with paroxysmal atrial fibrillation and is associated with CHADS2 score and peak velocity of left atrial appendage. J Cardiovasc Electrophysiol 2011;22:1325–30. http://dx.doi.org/10.1111/j.1540-8167.2011.02115.x
202. Chee K, Coles D, McGill D. Is P wave duration on 12-leads ECG useful to select ischemic stroke patients for 24h ambulatory Holter monitoring? Heart Lung Circ 2010;19:S220. https://doi.org/10.1016/j.hlc.2010.06.533
203. Choi S, Jiang Z. Cardiac sound murmurs classification with autoregressive spectral analysis and multi-support vector machine technique. Comput Biol Med 2010;40:8–20. http://dx.doi.org/10.1016/j.compbiomed.2009.10.003
204. Clavier L, Boucher JM, Lepage R, Blanc JJ, Cornily JC. Automatic P-wave analysis of patients prone to atrial fibrillation. Med Biol Eng Comput 2002;40:63–71. https://doi.org/10.1007/BF02347697
205. Cole-Haskayne AL, Pushie A, Gairdner S, Coutts S, Demchuk A. The use of cardiac event monitoring in ambulatory care for the detection of atrial fibrillation. Stroke 2014;45:E281.
206. Coutts SB, Choi PM. Seven days of non-invasive cardiac monitoring early postischaemic stroke or TIA increases atrial fibrillation detection rate compared with current guideline-based practice. Evid Based Med 2014;19:152. http://dx.doi.org/10.1136/eb-2013-101607
207. Cubanski D, Cyganski D, Antman EM, Feldman CL. A neural network system for detection of atrial fibrillation in ambulatory electrocardiograms. J Cardiovasc Electrophysiol 1994;5:602–8. https://doi.org/10.1111/j.1540-8167.1994.tb01301.x
208. Czaplik M, Eilebrecht B, Ntouba A, Walter M, Schauerte P, Leonhardt S, Rossaint R. Clinical proof of practicability for an ECG device without any conductive contact. Biomed Tech 2010;55:291–300. http://dx.doi.org/10.1515/BMT.2010.035
209. Dash S, Chon KH, Lu S, Raeder EA. Automatic real time detection of atrial fibrillation. Ann Biomed Eng 2009;37:1701–9. http://dx.doi.org/10.1007/s10439-009-9740-z
210. Dash S, Raeder E, Merchant S, Chon KH. A Statistical Approach for Accurate Detection of Atrial Fibrillation and Flutter. 36th Annual Computers in Cardiology Conference; 2009. pp. 137–40.
211. Dash S, Raeder E, Merchant S, Chon KH. A statistical approach for accurate detection of atrial fibrillation and flutter. J Electrocard 2011;44:e7. https://doi.org/10.1016/j.jelectrocard.2010.12.024
212. Davidenko JM, Snyder LS. Causes of errors in the electrocardiographic diagnosis of atrial fibrillation by physicians. J Electrocardiol 2007;40:450–6. https://doi.org/10.1016/j.jelectrocard.2007.01.003
213. Davy JM, Laurendeau C, Donio V, Spiess N, Briand Y. The French screening campaign of atrial fibrillation in general practice: assessment of predictive criteria for atrial fibrillation. Eur Heart J 2014;35:868.
214. Deelawar S, Manegold JC, Kalyani M, Tschishow WN, Ridjab D, Buddecke J, et al. Diagnostic yield of extended-time external loop recording for the detection of paroxysmal atrial fibrillation in patients with cryptogenic stroke. Europace 2013;15:2220.
215. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998;135:733–8. https://doi.org/10.1016/S0002-8703(98)70030-4
216. Dilaveris PE, Gialafos EJ, Chrissos D, Andrikopoulos GK, Richter DJ, Lazaki E, Gialafos JE. Detection of hypertensive patients at risk for paroxysmal atrial fibrillation during sinus rhythm by computer-assisted P wave analysis. J Hypertens 1999;17:1463–70. https://doi.org/10.1097/00004872-199917100-00015
217. Dirschedl P, Lenz S, Löllgen H, Fahrenkrog U. [Validity of telephone ECG multichannel transmission.] Z Kardiol 1996;85:677–83.
218. Dobbels L, Thijs V. Prospective comparison of continuous cardiac monitoring and Holter on a stroke unit. Eur J Neurol 2014;21(Suppl 1):116.
219. Dogan U, Dogan EA, Tekinalp M, Tokgoz OS, Aribas A, Akilli H, et al. P-wave dispersion for predicting paroxysmal atrial fibrillation in acute ischemic stroke. Int J Med Sci 2012;9:108–14. https://doi.org/10.7150/ijms.9.108
220. Doliwa PS, Frykman V, Rosenqvist M. Short-term ECG for out of hospital detection of silent atrial fibrillation episodes. Scand Cardiovasc J 2009;43:163–8. http://dx.doi.org/10.1080/14017430802593435
221. Doliwa Sobocinski P, Anggardh Rooth E, Frykman Kull V, von Arbin M, Wallen H, Rosenqvist M. Improved screening for silent atrial fibrillation after ischaemic stroke. Europace 2012;14:1112–16. https://doi.org/10.1093/europace/eur431
222. Dotan U, Dotan EA, Tekinalp M, Tokgoz OS, Aribas A, Akilli H, et al. Evaluation of potential predictive value of P-wave dispersion for predicting paroxysmal atrial fibrillation in patients with acute ischemic stroke. Turk Kardiyoloji Dernegi Ars 2011;39:196.
223. Douen AG, Pageau N, Medic S. Serial electrocardiographic assessments significantly improve detection of atrial fibrillation 2.6-fold in patients with acute stroke. Stroke 2008;39:480–2. http://dx.doi.org/10.1161/STROKEAHA.107.492595
224. Du X, Rao N, Qian M, Liu D, Li J, Feng W, et al. A novel method for real-time atrial fibrillation detection in electrocardiograms using multiple parameters. Ann Noninvasive Electrocardiol 2014;19:217–25. http://dx.doi.org/10.1111/anec.12111
225. Dukes JW, Whooley MA, Marcus GM. Cohort under-ascertainment of prevalent atrial fibrillation using the baseline 12-lead ECG: implications for atrial fibrillation ‘prediction’. Circulation 2014;130:A18479.
226. Duverney D, Gaspoz JM, Pichot V, Roche F, Brion R, Antoniadis A, Barthélémy JC. High accuracy of automatic detection of atrial fibrillation using wavelet transform of heart rate intervals. Pacing Clin Electrophysiol 2002;25:457–62. https://doi.org/10.1046/j.1460-9592.2002.00457.x
227. Elgendi M, Mahalingam S, Jonkman M, De Boer F. A Robust QRS Complex Detection Elgorithm Using Dynamic Thresholds. International Symposium on Computer Science and its Applications 2008. URL: www.researchgate.net/publication/232644395_A_Robust_QRS_Complex_Detection_Algorithm_using_Dynamic_Thresholds (accessed 16 January 2017).
228. Elijovich L, Josephson SA, Fung GL, Smith W. 30-day event monitors in detecting atrial fibrillation in cryptogenic stroke. Stroke 2008;39:584.
229. Engdahl J, Andersson L, Mirskaya M, Rosenqvist M. Stepwise screening for atrial fibrillation in a 75-year old population: implications for stroke prevention. Cerebrovasc Dis 2012;33(Suppl 2):830–1.
230. Feruglio GA, Feraco E, Maisano G. [The Caceres-USPHS (version HP-3) computer program. Evaluation of automatic analysis of 40,000 ECG.] G Ital Cardiol 1975;5:262–71.
231. Filos D, Chouvarda I, Dakos G, Vassilikos V, Maglaveras N. Beat to beat wavelet variability in atrial fibrillation. Conf Proc IEEE Eng Med Biol Soc 2011;2011:953–6. http://dx.doi.org/10.1109/IEMBS.2011.6090215
232. Finucane C, Frewen J, Nolan H, Murphy B, Kenny RA. Towards a smart app for increasing awareness and detection of atrial fibrillation in the community. Translating findings from the Irish longitudinal study on ageing into practice. Ir J Med Sci 2013;182:S214.
233. Foley PWX, Yung L, Barnes E. Comparison of wireless ambulatory cardiac monitoring with Holter monitoring. Europace 2011;13(Suppl 3).
234. Franczuk PK, Grodzicki T. [Sensitivity and specificity of high resolution electrocardiography in the identification of patients with paroxysmal atrial fibrillation.] Folia Cardiologica 2004;11:547–53.
235. Fukunami M, Yamada T, Ohmori M, Kumagai K, Umemoto K, Sakai A, et al. Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram. Circulation 1991;83:162–9. https://doi.org/10.1161/01.CIR.83.1.162
236. Fukunami M. Signal-averaged ECG for diagnosing paroxysmal atrial fibrillation. Primary Cardiol 1992;18:30–5.
237. Gaillard N, Vilotijevic B, Deltour S, Hornych A, Leger A, Crozier S, et al. Detection of paroxysmal atrial fibrillation in patients after cerebral ischemic events with transtelephonic ECG monitoring. Neurology 2008;70:A156-A.
238. Ghrooda EM, Dobrowolski P, Basir G, Yaseen I, Khan N, Ahmad A, et al. Paroxysmal atrial fibrillation is common in patients with defined etiology for stroke: prolonged monitoring of cardiac rhythm for detection of atrial fibrillation after a cerebral ischemic event (PEAACE) study. Stroke 2014;45(Suppl 1):A25.
239. Gialafos JE, Dilaveris PE, Gialafos EJ, Andrikopoulos GK, Richter DJ, Triposkiadis F, Kyriakidid MK. P wave dispersion: a valuable electrocardiographic marker for the prediction of paroxysmal lone atrial fibrillation. Ann Noninvasive Electrocardiol 1999;4:39–45. https://doi.org/10.1111/j.1542-474X.1999.tb00363.x
240. Gomis M, Millan M, De La Ossa NP, Dorado L, Guerrero C, Ricciardi AC, et al. Delayed ambulatory Holter for the detection of embolic arrhythmias after normal ECG continuous monitoring during 72 hours in acute ischemic stroke. Cerebrovasc Dis 2009;27:225.
241. Goricke B, Stahrenberg R, Weber-Kruger M, Seegers J, Edelmann F, Lahno R, et al. Atrial fibrillation: enhanced detection rates by prolonged Holter monitoring in stroke patients. Cerebrovasc Dis 2011;31:7.
242. Gradl S, Kugler P, Lohmuller C, Eskofier B. Real-time ECG monitoring and arrhythmia detection using Android-based mobile devices. Conf Proc IEEE Eng Med Biol Soc 2012;2012:2452–5. http://dx.doi.org/10.1109/EMBC.2012.6346460
243. Graja S, Boucher JM. SVM classification of patients prone to atrial fibrillation. 2005 IEEE International Workshop on Intelligent Signal Processing 2005. URL: www.researchgate.net/publication/4187535_SVM_Classification_of_patients_prone_to_atrial_fibrillation (accessed 16 January 2017).
244. Grond M, Rosin L, Kirchhof P. Detection of undiagnosed silent AF in patients with acute stroke. Cerebrovasc Dis 2011;31:33.
245. Grond M, Jauss M, Hamann G, Stark E, Veltkamp R, Nabavi D, et al. Improved detection of silent atrial fibrillation using 72-hour Holter ECG in patients with ischemic stroke: a prospective multicenter cohort study. Stroke 2013;44:3357–64. http://dx.doi.org/10.1161/STROKEAHA.113.001884
246. Guidera SA, Steinberg JS. The signal-averaged P wave duration: a rapid and noninvasive marker of risk of atrial fibrillation. J Am Coll Cardiol 1993;21:1645–51. https://doi.org/10.1016/0735-1097(93)90381-A
247. Güler I, Ubeyli ED. ECG beat classifier designed by combined neural network model. Pattern Recogn 2005;38:199–208. https://doi.org/10.1016/S0031-3203(04)00276-6
248. Gumbinger C, Hacke W, Ringleb P. Continuous monitoring vs. Holter ECG for detection of atrial fibrillation in patients with stroke. Cerebrovasc Dis 2010;29:167–8.
249. Gumbinger C, Krumsdorf U, Veltkamp R, Hacke W, Ringleb P. Continuous monitoring versus Holter ECG for detection of atrial fibrillation in patients with stroke. Eur J Neurol 2012;19:253–7. http://dx.doi.org/10.1111/j.1468-1331.2011.03519.x
250. Gunalp M, Atalar E, Coskun F, Yilmaz A, Aksoyek S, Aksu NM, Sivri B. Holter monitoring for 24 hours in patients with thromboembolic stroke and sinus rhythm diagnosed in the emergency department. Adv Ther 2006;23:854–60. https://doi.org/10.1007/BF02850206
251. Haberman ZC, Jahn RT, Bose R, Tun H, Shinbane JS, Doshi RN, et al. Wireless smart phone equipped ECG enables large scale screening in diverse populations. Heart Rhythm 2014;11:S312.
252. Haberman ZC, Jahn RT, Bose R, Tun H, Shinbane JS, Doshi RN, et al. Wireless smartphone ECG enables large-scale screening in diverse populations. J Cardiovasc Electrophysiol 2015;26:520–6. http://dx.doi.org/10.1111/jce.12634
253. Haeberlin A, Niederhauser T, Marisa T, Goette J, Jacomet M, Tanner H, et al. First validation of esophageal long-term electrocardiography as an alternative technique for long-term heart rhythm monitoring. Eur Heart J 2012;33:702.
254. Haeberlin A, Roten L, Schilling M, Scarcia F, Niederhauser T, Vogel R, et al. Software-based detection of atrial fibrillation in long-term ECGs. Heart Rhythm 2014;11:933–8. http://dx.doi.org/10.1016/j.hrthm.2014.03.014
255. Hakacova N, Trägårdh-Johansson E, Wagner GS, Maynard C, Pahlm O. Computer-based rhythm diagnosis and its possible influence on nonexpert electrocardiogram readers. J Electrocardiol 2012;45:18–22. http://dx.doi.org/10.1016/j.jelectrocard.2011.05.007
256. Hallioglu O, Aytemir K, Celiker A. The significance of P wave duration and P wave dispersion for risk assessment of atrial tachyarrhythmias in patients with corrected tetralogy of Fallot. Ann Noninvasive Electrocardiol 2004;9:339–44. https://doi.org/10.1111/j.1542-474X.2004.94569.x
257. Larkin Harrington J, Woon Chong J, Li J, Esa N, Pidikiti R, Maitas O, et al. The detection and differentiation of arrhythmias using a smartphone: a clinical study of patients with atrial fibrillation, premature atrial and premature ventricular contractions. J Am Coll Cardiol 2013;61:E362. https://doi.org/10.1016/S0735-1097(13)60362-9
258. Helfenbein E, Gregg R, Lindauer J, Zhou S. An automated algorithm for the detection of atrial fibrillation in the presence of paced rhythms. Comput Cardiol 2010;37:113–16.
259. Hendrikx T, Rosenqvist M, Sandstrom H, Hornsten R. Comparing efficacy of Holter ECG and handheld ECG in detecting relevant arrhythmias–the Primarytm study. Cerebrovasc Dis 2012;33:838–9.
260. Hendrikx T, Rosenqvist M, Wester P, Sandström H, Hörnsten R. Intermittent short ECG recording is more effective than 24-hour Holter ECG in detection of arrhythmias. BMC Cardiovasc Disord 2014;14:41. http://dx.doi.org/10.1186/1471-2261-14-41
261. Hickey B, Heneghan C, de Chazal P. Non-episode-dependent assessment of paroxysmal atrial fibrillation through measurement of RR interval dynamics and atrial premature contractions. Ann Biomed Eng 2004;32:677–87. https://doi.org/10.1023/B:ABME.0000030233.39769.a4
262. Higgins P, Dawson J, MacFarlane PW, McArthur K, Langhorne P, Lees KR. Predictive value of newly detected atrial fibrillation paroxysms in patients with acute ischemic stroke, for atrial fibrillation after 90 days. Stroke 2014;45:2134–6. http://dx.doi.org/10.1161/STROKEAHA.114.005405
263. Hiraki T, Ikeda H, Ohga M, Hamada T, Kubara I, Yoshida T, et al. Frequency- and time-domain analysis of P wave in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 1998;21:56–64. https://doi.org/10.1111/j.1540-8159.1998.tb01061.x
264. Hoffmann BA, Bakucz P, Rostock T, Steven D, Drewitz I, Sultan A, et al. Ultra-fast and accurate surface ECG detection of very short episodes of atrial fibrillation using wavelet transformation. Heart Rhythm 2010;7:S135.
265. Hong-Wei L, Ying S, Min L, Pi-Ding L, Zheng Z. A probability density function method for detecting atrial fibrillation using R–R intervals. Med Eng Phys 2009;31:116–23. http://dx.doi.org/10.1016/j.medengphy.2008.04.013
266. Horstmann S, Rizos T, Güntner J, Hug A, Jenetzky E, Krumsdorf U, Veltkamp R. Does the STAF score help detect paroxysmal atrial fibrillation in acute stroke patients? Eur J Neurol 2013;20:147–52. http://dx.doi.org/10.1111/j.1468-1331.2012.03816.x
267. Hoshino T, Nagao T, Shiga T, Maruyama K, Toi S, Mizuno S, et al. Prolonged QTc interval predicts poststroke paroxysmal atrial fibrillation. Stroke 2015;46:71–6. http://dx.doi.org/10.1161/STROKEAHA.114.006612
268. Howlett PJ, Morritt J, Jabr R, Mahmoudi M, Fry CH, Leatham EW. Targeted screening for paroxysmal atrial fibrillation: prolonged monitoring significantly increases diagnostic yield. Europace 2014;16:326. https://doi.org/10.1093/europace/euu243.4
269. Howlett P, Morritt J, Greswell L, Findlay N, Mahmoudi M, Waheed A, et al. Symptom frequency is a poor predictor of onset of paroxysmal atrial fibrillation in a population presenting with palpitations. Europace 2014;16:331. https://doi.org/10.1093/europace/euu244.7
270. Hsieh JC, Tzeng WC, Yang YC, Shieh SM, Ieee. Detecting ECG characteristic points by novel hybrid wavelet transforms: an evaluation of clinical SCP-ECG database. Comput Cardiol 2005;32:751–4. https://doi.org/10.1109/cic.2005.1588213
271. Inoue K, Shirayama T, Shiraishi H, Matoba Y, Imai H, Inoue D, Nakagawa M. Clinical significance of the atrial fibrillation threshold in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2001;24:796–805. https://doi.org/10.1046/j.1460-9592.2001.00796.x
272. Jang KJ, Balakrishnan G, Syed Z, Verma N. Scalable customization of atrial fibrillation detection in cardiac monitoring devices: increasing detection accuracy through personalized monitoring in large patient populations. Conf Proc IEEE Eng Med Biol Soc 2011;2011:2184–7. http://dx.doi.org/10.1109/IEMBS.2011.6090411
273. Jeon T, Kim B, Jeon M, Lee BG. Implementation of a portable device for real-time ECG signal analysis. Biomed Eng Online 2014;13:160. http://dx.doi.org/10.1186/1475-925X-13-160
274. Jiang K, Huang C, Ye SM, Chen H. High accuracy in automatic detection of atrial fibrillation for Holter monitoring. J Zhejiang Univ Sci B 2012;13:751–6. http://dx.doi.org/10.1631/jzus.B1200107
275. Joseph G, Zywietz C, Murray A, Swiryn S. Computerized ECG diagnosis on a reduced lead set (limb leads). Comput Cardiol 1999;26:687–90. https://doi.org/10.1109/cic.1999.826064
276. Kallmünzer B, Breuer L, Hering C, Raaz-Schrauder D, Kollmar R, Huttner HB, et al. A structured reading algorithm improves telemetric detection of atrial fibrillation after acute ischemic stroke. Stroke 2012;43:994–9. http://dx.doi.org/10.1161/STROKEAHA.111.642199
277. Kallmünzer B, Bobinger T, Kahl N, Kopp M, Kurka N, Hilz MJ, et al. Peripheral pulse measurement after ischemic stroke: a feasibility study. Neurology 2014;83:598–603. http://dx.doi.org/10.1212/WNL.0000000000000690
278. Kandel A, Ching MI, Covey TJ, Shucard DW. Timing of mobile cardiac outpatient telemetry may increase diagnostic yield of atrial fibrillation in select patients with cryptogenic strokes. Stroke 2012;43:A2437.
279. Kar A, Ellis A, Guyler P, O’Brien A. Intensive cardiac monitoring after transient ischaemic attack identifies a significant number of previously unknown paroxysmal atrial fibrillation. Int J Stroke 2009;4:1.
280. Karapinar H, Kaya Z, Pala S, Karavelioglu Y, Dasli T, Sirma D, et al. Predictive value of atrial electromechanical coupling time for paroxysmal atrial fibrillation. Eur Heart J 2009;30:561–2.
281. Kessler DK, Kessler KM. Is ambulatory electrocardiography beneficial to detect atrial-fibrillation in patients with stroke? Clin Res 1993;41:A811.
282. Kikillus N, Hammer G, Wieland S, Bolz A. Algorithm for identifying patients with paroxysmal atrial fibrillation without appearance on the ECG. Conf Proc IEEE Eng Med Biol Soc 2007;2007:275–8. http://dx.doi.org/10.1109/IEMBS.2007.4352277
283. Kikillus N, Hammer G, Bolz A. [Identification of patients with atrial fibrillation using HRV parameters.] Biomed Tech 2008;53:8–15. http://dx.doi.org/10.1515/BMT.2008.002
284. Kim D, Seo Y, Youn CH. Detection of atrial fibrillation episodes using multiple heart rate variability features in different time periods. Conf Proc IEEE Eng Med Biol Soc 2008;2008:5482–5. http://dx.doi.org/10.1109/IEMBS.2008.4650455
285. Kim SH, Oh YS, Kim BK, Ha YW, Park JW, Kim TS, et al. Diagnostic usefulness of prolonged and real-time rhythm monitoring using mobile phone. Heart Rhythm 2013;10:S22–3.
286. Kinlay S, Leitch JW, Neil A, Chapman BL, Hardy DB, Fletcher PJ. Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations. A controlled clinical trial. Ann Intern Med 1996;124:16–20. https://doi.org/10.7326/0003-4819-124-1_Part_1-199601010-00003
287. Klein MD, Key-Brothers I, Feldman CL, Can the vectorcardiographically derived EASI ECG be a suitable surrogate for the standard ECG in selected circumstances. Comput Cardiol 1997;24:721–4. https://doi.org/10.1109/cic.1997.648152
288. Köse S, Aytemir K, Sade E, Can I, Ozer N, Amasyali B, et al. Detection of patients with hypertrophic cardiomyopathy at risk for paroxysmal atrial fibrillation during sinus rhythm by P-wave dispersion. Clin Cardiol 2003;26:431–4. https://doi.org/10.1002/clc.4960260910
289. Koskinen R, Lehto M, Väänänen H, Rantonen J, Voipio-Pulkki LM, Mäkijärvi M, et al. Measurement and reproducibility of magnetocardiographic filtered atrial signal in patients with paroxysmal lone atrial fibrillation and in healthy subjects. J Electrocardiol 2005;38:330–6. https://doi.org/10.1016/j.jelectrocard.2005.03.012
290. Kostka PS, Tkacz EJ. Feature extraction and selection algorithms in biomedical data classifiers based on time-frequency and principle component analysis. In 11th Mediterranean Conference on Medical and Biological Engineering and Computing, 2007. pp. 70–3. https://doi.org/10.1007/978-3-540-73044-6_19
291. Kostka PS, Tkacz EJ. Feature extraction based on time-frequency and independent component analysis for improvement of separation ability in atrial fibrillation detector. Conf Proc IEEE Eng Med Biol Soc 2008;2008:2960–3. http://dx.doi.org/10.1109/IEMBS.2008.4649824
292. Kostka PS, Tkacz EJ. Feature extraction for improving the support vector machine biomedical data classifier performance. In International Special Topic Conference on Information Technology and Applications in Biomedicine, 2008. pp. 434–7. https://doi.org/10.1109/itab.2008.4570638
293. Kostka P, Tkacz E. Support Vector Machine with Rule Extraction for Medical Signal Classification. 19th International EURASIP Conference Biosignal, 30 June–1 July 2008, Brno, Czech Republic, abstract no. 45.
294. Kostka PS, Tkacz EJ. Feature selection based on time-frequency analysis in SVM classifier with rules extraction stage. In Dössel O, Schlegel WC, editors. Proceedings of the World Congress 2009 for Medical Physics and Biomedical Engineering, vol. 25/IV: Image Processing, Biosignal Processing, Modelling and Simulation, Biomechanics. pp. 2261–4. https://doi.org/10.1007/978-3-642-03882-2_601
295. Kostka PS, Tkacz EJ. Feature extraction in time-frequency signal analysis by means of matched wavelets as a feature generator. Conf Proc IEEE Eng Med Biol Soc 2011;2011:4996–9. http://dx.doi.org/10.1109/IEMBS.2011.6091238
296. Krasteva V, Jekova I. QRS template matching for recognition of ventricular ectopic beats. Ann Biomed Eng 2007;35:2065–76. http://dx.doi.org/10.1007/s10439-007-9368-9
297. Lagido RB, Lobo J, Leite S, Sousa C, Ferreira L, Silva-Cardoso J, et al. Using the smartphone camera to monitor heart rate and rhythm in heart failure patients. Proceedings of the 2014 IEEE-EMBS International Conference on Biomedical and Health Informatics. pp. 556–9. https://doi.org/10.1109/BHI.2014.6864425
298. Lalani GG, Schricker AA, Clopton P, Krummen DE, Narayan SM. Frequency analysis of atrial action potential alternans: a sensitive clinical index of individual propensity to atrial fibrillation. Circ Arrhythm Electrophysiol 2013;6:859–67. http://dx.doi.org/10.1161/CIRCEP.113.000204
299. Langley P, di Bernardo D, Allen J, Bowers E, Smith FE, Vecchietti S, et al. Can paroxysmal atrial fibrillation be predicted? Comput Cardiol 2001;28:121–4. https://doi.org/10.1109/cic.2001.977606
300. Lau J, Lowres N, Neubeck L, Brieger DB, Sy RW, Galloway C, et al. Validation of an iphone ECG application suitable for community screening for silent atrial fibrillation: a novel way to prevent stroke. Circulation 2012;126:A16810.
301. Lavallee PC, Benchimol H, Labreuche J, Meseguer E, Mazighi M, Guidoux C, et al. Feasibility and sensibility of daily transtelephonic EKG monitoring to detect paroxysmal atrial fibrillation in a selected population of stroke patients. Cerebrovasc Dis 2013;35:429.
302. Lazzaro MA, Krishnan K, Prabhakaran S. The presence of supraventricular tachycardia may be a marker of paroxysmal atrial fibrillation in acute ischemic stroke and TIA patients. Cerebrovasc Dis 2010;29:155.
303. Lazzaro MA, Krishnan K, Prabhakaran S. Detection of atrial fibrillation with concurrent Holter monitoring and continuous cardiac telemetry following ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis 2012;21:89–93. http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2010.05.006
304. Lee J, McManus D, Chon K. Atrial fibrillation detection using time-varying coherence function and Shannon entropy. Conf Proc IEEE Eng Med Biol Soc 2011;2011:4685–8. http://dx.doi.org/10.1109/IEMBS.2011.6091160
305. Lee J, Nam Y, McManus DD, Chon KH. Time-varying coherence function for atrial fibrillation detection. IEEE Trans Biomed Eng 2013;60:2783–93. http://dx.doi.org/10.1109/TBME.2013.2264721
306. Lee J, Reyes BA, McManus DD, Maitas O, Mathias O, Chon KH. Atrial fibrillation detection using an iPhone 4S. IEEE Trans Biomed Eng 2013;60:203–6. http://dx.doi.org/10.1109/TBME.2012.2208112
307. Lelakowska-Pieła M, Pudło J, Engel A, Lelakowski J. [Analysis of P wave duration and dispersion in paroxysmal atrial fibrillation.] Pol Merkur Lekarski 2013;35:259–62.
308. Lepage R, Boucher JM, Blanc JJ, Cornilly JC, Ieee, Ieee, et al. ECG segmentation and P-wave feature extraction: application to patients prone to atrial fibrillation. Proceedings of the 23rd Annual International Conference of the IEEE Engineering in Medicine and Biology Society, vols 1–4: Building New Bridges at the Frontiers of Engineering and Medicine; 2001. pp. 298–301.
309. Lever NA, Larsen PD, Dawes M, Wong A, Harding SA. Are our medical graduates in New Zealand safe and accurate in ECG interpretation? N Z Med J 2009;122:9–15.
310. Lewalter T, Remerie S, Yang A, Schrickel JW, Stoeckigt F, Andrie R, et al. Detection of atrial fibrillation: sensitivity of various ECG monitoring approaches. Eur Heart J 2007;28:537.
311. Lim HS, Lip GY. Asymptomatic atrial fibrillation on device interrogation. J Cardiovasc Electrophysiol 2008;19:891–3. http://dx.doi.org/10.1111/j.1540-8167.2008.01194.x
312. Linker DT, Dziubinski MJ, Badelt SW, Swerdlow CD. Accurate, unsupervised screening of Holter recordings for diagnosing atrial fibrillation. Heart Rhythm 2013;10:S167.
313. Liu CS, Tseng WK, Lee JK, Hsiao TC, Lin CW. The differential method of phase space matrix for AF/VF discrimination application. Med Eng Phys 2010;32:444–53. http://dx.doi.org/10.1016/j.medengphy.2010.04.001
314. Locati ET, Vecchi AM, Cattafi G, Sachero A, Lunati M. Role of new external loop recorders (ELR) with auto-trigger functions and high-memory capacity in a step-wise approach for the clinical diagnosis of infrequent arrhythmic events. Europace 2011;13:P675.
315. Logan B, Healey J. Robust detection of atrial fibrillation for a long term telemonitoring system. Comput Cardiol 2005;32:619–22. https://doi.org/10.1109/cic.2005.1588177
316. Lu H. [Detecting atrial fibrillation and normal sinus rhythm by R–R intervals.] Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2010;27: 183–7.
317. Madsen C, Henriksen IO, Tveskov C. Value of 48 hour telemetry of all acute stroke patients in detecting paroxysmal atrial fibrillation. Cerebrovasc Dis 2009;27:44.
318. Mahagne MH, Suissa L, Bertora D, Lachaud S. Score for targeting of atrial fibrillation (STAF): a new approach for detection of atrial fibrillation in ischemic stroke patients? Cerebrovasc Dis 2009;27:65.
319. Mahagne MH, Suissa L, Lachaud S. Continuous bedside ECG monitoring: an interesting method to increase atrial fibrillation diagnosing rate in stroke patients. Cerebrovasc Dis 2011;31:295.
320. Maier C, Bauch M, Dickhaus H. Screening and prediction of paroxysmal atrial fibrillation by analysis of heart rate variability parameters. Comput Cardiol 2001;28:129–32. https://doi.org/10.1109/cic.2001.977608
321. Mairesse GH, Scavee C, Claes N, Goethals P, Vijgen J, Blankoff I, et al. Similar heart rates between atrial fibrillation and sinus rhythm in asymptomatic populations justify large scale screening to improve the detection of atrial fibrillation. Europace 2013;15:2224.
322. Maitas O, Lee J, Robotis D, Bourell P, Chon KH, McManus DD. Detection of atrial fibrillation using an iphone 4S. Circulation 2012;126:A9298.
323. Maitas O, Lee J, Robotis D, Chon KH, McManus DD. Detection of atrial fibrillation using a smartphone camera. Circ Res 2012;111 A55.
324. Mäkijärvi M, Nenonen J, Toivonen L, Montonen J, Katila T, Siltanen P. Magnetocardiography: supraventricular arrhythmias and preexcitation syndromes. Eur Heart J 1993;14(Suppl E):46–52. https://doi.org/10.1093/eurheartj/14.suppl_E.46
325. Makowska E, Szymot J, Soszyriska M, Kulakowski P. Evaluation of patients with palpitations: cardiac event recorder versus 48-hour Holter monitoring. Ann Noninvasive Electrocardiol 2000;5:315–21. https://doi.org/10.1111/j.1542-474X.2000.tb00068.x
326. Manina G, Agnelli G, Becattini C, Zingarini G, Paciaroni M. 96 hours ECG monitoring for patients with ischemic cryptogenic stroke or transient ischaemic attack. Intern Emerg Med 2014;9:65–7. http://dx.doi.org/10.1007/s11739-012-0755-3
327. Martínez A, Alcaraz R, Rieta JJ. Study on the P-wave feature time course as early predictors of paroxysmal atrial fibrillation. Physiol Meas 2012;33:1959–74. http://dx.doi.org/10.1088/0967-3334/33/12/1959
328. Martinez-Sanchez P, Cruz-Herranz A, Correas E, Fuentes B, Cazorla-Garcia R, Martinez-Martinez M, et al. Diagnosis of paroxysmal atrial fibrillation combining cardiac and Holter monitoring in patients with acute brain ischemia. Eur J Neurol 2011;18:115.
329. Martinez-Sanchez P, Callero EC, Herranz AC, Gimeno BF, Montes AM, De Los Angeles Mangas Guijarro M, et al. Detection of paroxysmal atrial fibrillation in patient with acute brain ischemia combining cardiac and Holter monitoring: prevalence and predictors. Stroke 2012;43:A3648.
330. Martis RJ, Acharya UR, Adeli H, Prasad H, Tan JH, Chua KC, et al. Computer aided diagnosis of atrial arrhythmia using dimensionality reduction methods on transform domain representation. Biomed Signal Process Control 2014;13:295–305. https://doi.org/10.1016/j.bspc.2014.04.001
331. Maslowsky F, Sarzi Braga S, Pedretti RFE, Tramarin R. Atrial depolarization dispersion on Holter monitoring is an useful marker of atrial fibrillation after cardiac surgery. Eur J Prev Cardiol 2012;19:S133.
332. McCarthy L. ACP Journal Club: ambulatory ECG monitoring for 30 d increased AF detection more than 24 h of ECG monitoring after cryptogenic stroke. Ann Intern Med 2014;161:JC2. http://dx.doi.org/10.7326/0003-4819-161-10-201411180-02002
333. Miller DJ, Khan M, Schultz L, Simpson JR, Russman A, Panayiotis M. Outpatient cardiac telemetry detects a high rate of atrial fibrillation among patients with cryptogenic cerebral ischemia. Stroke 2012;43:A150.
334. Miller DJ. Randomised controlled trial: prolonged cardiac monitoring after cryptogenic stroke superior to 24 h ECG in detection of occult paroxysmal atrial fibrillation. Evid Based Med 2014;19:235. https://doi.org/10.1136/ebmed-2014-110074
335. Mohebbi M, Ghassemian H. Detection of atrial fibrillation episodes using SVM. Conf Proc IEEE Eng Med Biol Soc 2008;2008:177–80. http://dx.doi.org/10.1109/IEMBS.2008.4649119
336. Mohebbi M, Ghassemian H. Prediction of paroxysmal atrial fibrillation based on non-linear analysis and spectrum and bispectrum features of the heart rate variability signal. Comput Methods Programs Biomed 2012;105:40–9. http://dx.doi.org/10.1016/j.cmpb.2010.07.011
337. Montereggi A, Marconi P, Olivotto I, Castelli G, Dolara A, Luisi ML, Gheri RG. Signal-averaged P-wave duration and risk of paroxysmal atrial fibrillation in hyperthyroidism. Am J Cardiol 1996;77:266–9. https://doi.org/10.1016/S0002-9149(97)89391-5
338. Moreira JO, Moffa PJ, Uchida AH, Tobias NM, Grupi CJ, Luna Filho B, Tarasoutchi F. The signal-averaged electrocardiogram of atrial activation in patients with or without paroxysmal atrial fibrillation. Arq Bras Cardiol 2006;87:564–9.
339. Mueller A, Och W, Schweizer J. Automatic detection of atrial fibrillation and telemedical ECG transmission via a loop recorder. Eur Heart J 2006;27:139.
340. Müller A, Scharner W, Borchardt T, Och W, Korb H. Reliability of an external loop recorder for automatic recognition and transtelephonic ECG transmission of atrial fibrillation. J Telemed Telecare 2009;15:391–6. http://dx.doi.org/10.1258/jtt.2009.090402
341. Murgatroyd FD, Xie BY, Copie X, Blankoff I, Camm AJ, Malik M. Identification of atrial fibrillation episodes in ambulatory electrocardiographic recordings: validation of a method for obtaining labeled R–R interval files. Pacing Clin Electrophysiol 1995;18:1315–20. https://doi.org/10.1111/j.1540-8159.1995.tb06972.x
342. Opolski G, Kraska T, Piatkowska-Janko E, Słomka K, Górecki A, Stanisławska J, et al. [P-wave EKG averaging technique–a new method of selecting patients with paroxysmal atrial fibrillation.] Pol Tyg Lek 1995;50:39–41.
343. Ozdemir O, Soylu M, Demir AD, Topaloglu S, Alyan O, Turhan H, et al. P-wave durations as a predictor for atrial fibrillation development in patients with hypertrophic cardiomyopathy. Int J Cardiol 2004;94:163–6. http://dx.doi.org/10.1016/j.ijcard.2003.01.001
344. Ozer N, Aytemir K, Atalar E, Sade E, Aksöyek S, Ovünç K, et al. P wave dispersion in hypertensive patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2000;23:1859–62. https://doi.org/10.1111/j.1540-8159.2000.tb07038.x
345. Park J, Lee S, Jeon M. Atrial fibrillation detection by heart rate variability in Poincare plot. Biomed Eng Online 2009;8:38. http://dx.doi.org/10.1186/1475-925X-8-38
346. Pastor-Pérez FJ, Manzano-Fernández S, Goya-Esteban R, Pascual-Figal DA, Barquero-Pérez O, Rojo-Alvarez JL, et al. Comparison of detection of arrhythmias in patients with chronic heart failure secondary to non-ischemic versus ischemic cardiomyopathy by 1 versus 7-day Holter monitoring. Am J Cardiol 2010;106:677–81. http://dx.doi.org/10.1016/j.amjcard.2010.04.027
347. Peer C, Schreier G, Kastner P, Marko W, Messmer J, Rotman B, et al. easyG–electrocardiogram analysis system Graz. 4th International IEEE EMBS Special Topic Conference on Information Technology Applications in Biomedicine. Conference Proceedings: New Solutions for New Challenges; 2003 pp. 338–41.
348. Pellise A, Ustrell X, Milian M, Merce J, Vinas J, Mares R. Enhanced detection of occult atrial fibrillation by 24 hour Holter monitoring in selected patients with acute ischemic stroke. Cerebrovasc Dis 2011;31:296.
349. Poon K, Okin PM, Kligfield P. Diagnostic performance of a computer-based ECG rhythm algorithm. J Electrocardiol 2005;38:235–8. https://doi.org/10.1016/j.jelectrocard.2005.01.008
350. Portet F. P wave detector with PP rhythm tracking: evaluation in different arrhythmia contexts. Physiol Meas 2008;29:141–55. http://dx.doi.org/10.1088/0967-3334/29/1/010
351. Potpara TS, Lane DA. Diving to the foot of an iceberg: the SEARCH for undiagnosed atrial fibrillation. Thromb Haemost 2014;112:1–3. http://dx.doi.org/10.1160/TH14-05-0437
352. Pryor TA, Lindsay AE, England RW. Computer analysis of serial electrocardiograms. Comput Biomed Res 1972;5:709–14. https://doi.org/10.1016/0010-4809(72)90049-3
353. Pusalkar A, Venter M, Banerjee S, Kar A, Ames D. Inpatient continuous cardiac telemetry on a hyper-acute stroke unit increases the detection of paroxysmal atrial fibrillation after stroke and TIA. Cerebrovasc Dis 2012;33:839–40.
354. Quinto Villani G, Rosi A, Dieci G, Arruzzoli S, Gazzola U. [The high-resolution analysis of the P wave recorded via the esophagus: a new diagnostic approach in patients with paroxysmal atrial fibrillation.] G Ital Cardiol 1993;23:139–44.
355. Rabinstein AA. Prolonged cardiac monitoring for detection of paroxysmal atrial fibrillation after cerebral ischemia. Stroke 2014;45:1208–14. http://dx.doi.org/10.1161/STROKEAHA.113.003389
356. Reddy BR, Taha B, Swiryn S, Silberman R, Childers R. Prospective evaluation of a microprocessorassisted cardiac rhythm algorithm: results from one clinical center. J Electrocardiol 1998;30:28–33. https://doi.org/10.1016/S0022-0736(98)80016-2
357. Reifart N, Weil HJ, Göhring S, Dietl J. [The reliability of a new 12-channel ECG with telephone transmission.] Dtsch Med Wochenschr 1997;122:1137–40. http://dx.doi.org/10.1055/s-2008-1047739
358. Renier W, Geelen M, Steverlynck L, Wauters J, Aertgeerts B, Verbakel J, et al. Can the heartscan be used for diagnosis and monitoring of emergencies in general practice? Acta Cardiol 2012;67:525–31. http://dx.doi.org/10.2143/AC.67.5.2174126
359. Rhys GC, Mohammed F, Foster A. Screening for AF in patients 65 years and over attending annual flu vaccination clinics at Moorlands Medical Centre. Int J Stroke 2012;7:73.
360. Rincon F, Grassi PR, Khaled N, Atienza D, Sciuto D. Automated real-time atrial fibrillation detection on a wearable wireless sensor platform. Conf Proc IEEE Eng Med Biol Soc 2012;2012:2472–5. http://dx.doi.org/10.1109/EMBC.2012.6346465
361. Rizikou D, Margariti A, Labakis M, Vangelis S, Makrygiannis S, Labakis S, et al. Clinical suspicion of nursing personnel in the identification and prevention of atrial fibrillation in intensive care unit patients. Intensive Care Med 2013;39:S403.
362. Rizos T, Rasch C, Jenetzky E, Hametner C, Kathoefer S, Reinhardt R, et al. Detection of paroxysmal atrial fibrillation in acute stroke patients. Cerebrovasc Dis 2010;30:410–7. http://dx.doi.org/10.1159/000316885
363. Rizos T, Güntner J, Jenetzky E, Marquardt L, Reichardt C, Becker R, et al. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke 2012;43:2689–94. https://doi.org/10.1161/STROKEAHA.112.654954
364. Roche F, Gaspoz JM, Da Costa A, Isaaz K, Duverney D, Pichot V, et al. Frequent and prolonged asymptomatic episodes of paroxysmal atrial fibrillation revealed by automatic long-term event recorders in patients with a negative 24-hour Holter. Pacing Clin Electrophysiol 2002;25:1587–93. https://doi.org/10.1046/j.1460-9592.2002.01587.x
365. Ros E, Mota S, Toro FJ, Díaz AF, Fernández FJ. Automatic paroxysmal atrial fibrillation based on not fibrillating ECGs. Methods Inf Med 2004;43:94–8.
366. Roten L, Schilling M, Häberlin A, Seiler J, Schwick NG, Fuhrer J, et al. Is 7-day event triggered ECG recording equivalent to 7-day Holter ECG recording for atrial fibrillation screening? Heart 2012;98:645–9. http://dx.doi.org/10.1136/heartjnl-2011-301455
367. Samol A, Masin M, Gellner R, Otte B, Pavenstädt HJ, Ringelstein EB, et al. Prevalence of unknown atrial fibrillation in patients with risk factors. Europace 2013;15:657–62. http://dx.doi.org/10.1093/europace/eus366
368. Sanak D, Kral M, Hutyra M, Bartkova A, Fedorco M, Zapletalova J, et al. Heart and brain long-term ECG-Holter monitoring in detection of paroxysmal atrial fibrillation in young cryptogenic ischemic stroke patients. Int J Stroke 2014;9:201–2.
369. Sato H, Takaki H, Shimizu W, Kamakura S, Sugimachi M. Magnetocardiography can identify abnormal atrial electrical activities during sinus rhythm in patients with paroxysmal atrial fibrillation. Eur Heart J 2009;30:559.
370. Sawant AC, Te Riele AS, Sandhu O, Sandhu L, Srivatsa S. Smartphone based applications accurately predict rhythm disturbances and diagnose silent atrial fibrillation. Heart Rhythm 2014;11:S230. https://doi.org/10.1016/s0735-1097(14)60299-0
371. Schaefer JR, Leussler D, Rosin L, Pittrow D, Hepp T. Improved detection of paroxysmal atrial fibrillation utilizing a software-assisted electrocardiogram approach. PLOS ONE 2014;9:e89328. http://dx.doi.org/10.1371/journal.pone.0089328
372. Schaer BA, Cron TA, Osswald S. Value of routine Holter screening for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemic attacks. J Am Coll Cardiol 2003;41:531A. https://doi.org/10.1016/S0735-1097(03)82848-6
373. Schreier G, Kastner P, Marko W. An automatic ECG processing algorithm to identify patients prone to paroxysmal atrial fibrillation. Comput Cardiol 2001;28:133–5. https://doi.org/10.1109/cic.2001.977609
374. Schuchert A, Behrens G, Meinertz T. Impact of long-term ECG recording on the detection of paroxysmal atrial fibrillation in patients after an acute ischemic stroke. Pacing Clin Electrophysiol 1999;22:1082–4. https://doi.org/10.1111/j.1540-8159.1999.tb00574.x
375. Sezgin N. Nonlinear analysis of electrocardiography signals for atrial fibrillation. Sci World J 2013;2013:509784. http://dx.doi.org/10.1155/2013/509784
376. Shafqat S, Kelly PJ, Furie KL. Holter monitoring in the diagnosis of stroke mechanism. Intern Med J 2004;34:305–9. http://dx.doi.org/10.1111/j.1444-0903.2004.00589.x
377. Sheldon SH, Baturova MA, Platonov PG, Brady PA, Lin G, Rabinstein A, et al. Use of left atrial volume index to rule out paroxysmal atrial fibrillation on ambulatory electrocardiographic monitoring in patients with ischemic stroke. Heart Rhythm 2014;11:S392.
378. Shiyovich A, Wolak A, Yacobovich L, Grosbard A, Katz A. Accuracy of diagnosing atrial flutter and atrial fibrillation from a surface electrocardiogram by hospital physicians: analysis of data from internal medicine departments. Am J Med Sci 2010;340:271–5. http://dx.doi.org/10.1097/MAJ.0b013e3181e73fcf
379. Singh D, Xiang C, Tat HTC, Nan LQS, Yeo WT, Poh KK, et al. Validation study of a real-time wireless, cell phone-based single lead electrocardiographic monitoring system in dysrrhythmia. Circulation 2010;122:e385.
380. Sobocinski-Doliwa P, Rooth E, Frykman V, Von Arbin M, Wallen H, Rosenqvist M. Improved screening for silent atrial fibrillation after ischemic stroke. Scand Cardiovasc J 2010;44:10.
381. Stafford PJ, Robinson D, Vincent R. Optimal analysis of the signal averaged P wave in patients with paroxysmal atrial fibrillation. Br Heart J 1995;74:413–18. https://doi.org/10.1136/hrt.74.4.413
382. Stahrenberg R, Weber-Krüger M, Seegers J, Edelmann F, Lahno R, Haase B, et al. Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous Holter monitoring in patients with cerebral ischemia presenting in sinus rhythm. Stroke 2010;41:2884–8. http://dx.doi.org/10.1161/STROKEAHA.110.591958
383. Sudlow M, Rodgers H, Kenny RA, Thomson R. Identification of patients with atrial fibrillation in general practice: a study of screening methods. BMJ 1998;317:327–8. https://doi.org/10.1136/bmj.317.7154.327
384. Sugai TK, Yoshizawa M, Abe M, Shimizu K, Inagaki M, Sugimachi M, Sunagawa K. Preliminary study on the detection of cardiac arrhythmias based on multiple simultaneous electrograms. Conf Proc IEEE Eng Med Biol Soc 2009;2009:2498–501. http://dx.doi.org/10.1109/IEMBS.2009.5335157
385. Suissa L, Mahagne MH, Lachaud S. Score for the targeting of atrial fibrillation: a new approach to diagnosing paroxysmal atrial fibrillation. Cerebrovasc Dis 2011;31:442–7. http://dx.doi.org/10.1159/000323852
386. Suissa L, Bresch S, Lachaud S, Mahagne MH. What pertinent parameter(s) to rule out paroxysmal atrial fibrillation (pAF) in stroke patients? Cerebrovasc Dis 2012;33:76.
387. Suissa L, Bresch S, Lachaud S, Mahagne MH. Optimal timing and duration of continuous ECG monitoring for detecting atrial fibrillation in stroke patients. Cerebrovasc Dis 2012;33:77.
388. Suissa L, Lachaud S, Mahagne MH. Optimal timing and duration of continuous electrocardiographic monitoring for detecting atrial fibrillation in stroke patients. J Stroke Cerebrovasc Dis 2013;22:991–5. http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2012.01.015
389. Suissa L, Lachaud S, Mahagne MH. Continuous ECG monitoring for tracking down atrial fibrillation after stroke: Holter or automated analysis strategy? Eur Neurol 2014;72:7–12. http://dx.doi.org/10.1159/000358053
390. Sun R, Wang Y, Yang S, Fang Z. [Detecting cardiac arrhythmias based on phase space analysis.] Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2008;25:934–7, 949.
391. Sutamnartpong P, Dharmasaroja PA, Ratanakorn D, Arunakul I. Atrial fibrillation and paroxysmal atrial fibrillation detection in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 2014;23:1138–41. http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2013.09.032
392. Tagawa M, Takeuchi S, Chinushi M, Saeki M, Taniguchi Y, Nakamura Y, et al. Evaluating patients with acute ischemic stroke with special reference to newly developed atrial fibrillation in cerebral embolism. Pacing Clin Electrophysiol 2007;30:1121–8. https://doi.org/10.1111/j.1540-8159.2007.00823.x
393. Tateno K, Glass L. Automatic detection of atrial fibrillation using the coefficient of variation and density histograms of RR and deltaRR intervals. Med Biol Eng Comput 2001;39:664–71. https://doi.org/10.1007/BF02345439
394. Temiz A, Gazi E, Güngör O, Altun B, Barutcu A, Bekler A, et al. Fragmented QRS and prediction of paroxysmal atrial fibrillation episodes. Pak J Med Sci 2014;30:862–7. https://doi.org/10.12669/pjms.304.5064
395. Tieleman RG, Plantinga Y, Rinkes D, Bartels GL, Posma JL, Cator R, et al. Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation. Europace 2014;16:1291–5. http://dx.doi.org/10.1093/europace/euu057
396. Torbey S, Akl SG, Redfearn DP. Automated detection of paroxysmal atrial fibrillation in sinus rhythm. Can J Cardiol 2013;29:S127. https://doi.org/10.1016/j.cjca.2013.07.176
397. Tu HT, Spence S, Kalman JM, Davis SM. Twenty-eight day Holter monitoring is poorly tolerated and insensitive for paroxysmal atrial fibrillation detection in cryptogenic stroke. Intern Med J 2014;44:505–8. http://dx.doi.org/10.1111/imj.12410
398. Tung CE, Su D, Turakhia MP, Lansberg MG. Diagnostic yield of extended cardiac patch monitoring in patients with stroke or TIA. Front Neurol 2014;5:266. http://dx.doi.org/10.3389/fneur.2014.00266
399. Ustrell X, Pellise A, Milian M, Merce J, Vinas J, Mares R. Improved detection of unknown atrial fibrillation in acute stroke patients through prolonged serial daily ECG assessments. Cerebrovasc Dis 2011;31:297.
400. Velthuis BO, Bos J, Kraaier K, Stevenhagen J, van Opstal JM, van der Palen J, Scholten MF. Performance of an external transtelephonic loop recorder for automated detection of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 2013;18:564–70. http://dx.doi.org/10.1111/anec.12075
401. Veltkamp R, Rizos T, Guntner J, Jenetzky E, Reichardt C, Hepp T, et al. Continuous stroke unit ECG monitoring detects intermittent atrial fibrillation more sensitively than 24 h Holter ECG after acute stroke and TIA. Cerebrovasc Dis 2011;31:31.
402. Veltkamp R, Guentner J, Jenetzky E, Becker R, Kirchhof P, Reinhardt R, et al. Continuous stroke unit ECG monitoring is better than 24-h Holter ECG for detection of paroxysmal atrial fibrillation after stroke. Stroke 2012;43:A131.
403. Villani GQ, Piepoli M, Rosi A, Capucci A. P-wave dispersion index: a marker of patients with paroxysmal atrial fibrillation. Int J Cardiol 1996;55:169–75. https://doi.org/10.1016/0167-5273(96)02677-0
404. Villani M, Iannucci G, Iannuzzi S, Machella L, Baciarello G. New parameters able to better identify patients at risk of atrial fibrillation. Heartweb 1996;2:U10–16.
405. Vinther KH, Tveskov C, Rosen T, Auscher S, Egstrup K. Detection of atrial fibrillation in patients with ischemic stroke by continuous in-hospital cardiac telemetry. Eur Heart J 2014;35:814.
406. Vyas V, Duran J, Ansaripour A, Niedzielko M, Steel A, Bakhai A. Does a 12-lead ECG more reliably detect atrial fibrillation than a rhythm strip only ECG? Value Health 2014;17:A485–6. http://dx.doi.org/10.1016/j.jval.2014.08.1421
407. Wallmann D, Tüller D, Wustmann K, Meier P, Isenegger J, Arnold M, et al. Frequent atrial premature beats predict paroxysmal atrial fibrillation in stroke patients: an opportunity for a new diagnostic strategy. Stroke 2007;38:2292–4. https://doi.org/10.1161/STROKEAHA.107.485110
408. Wiesel J, Wiesel D, Suri R, Messineo FC. The use of a modified sphygmomanometer to detect atrial fibrillation in outpatients. Pacing Clin Electrophysiol 2004;27:639–43. http://dx.doi.org/10.1111/j.1540-8159.2004.00499.x
409. Wiesel J, Messineo FC, Wiesel D. Screening for atrial fibrillation at home using a modified sphygmomanometer. Stroke 2007;38:539.
410. Wiesel J, Fitzig L, Herschman Y, Messineo FC. Detection of atrial fibrillation using a modified microlife blood pressure monitor. Am J Hypertens 2009;22:848–52. http://dx.doi.org/10.1038/ajh.2009.98
411. Wiesel J, Abraham S, Messineo FC. Detecting atrial fibrillation at home with a novel blood pressure monitor with atrial fibrillation detection functionality. J Am Coll Cardiol 2010;55(10 Suppl.):A15.E144.
412. Wiesel J, Abraham S, Messineo FC. Screening for asymptomatic atrial fibrillation while monitoring the blood pressure at home: trial of regular versus irregular pulse for prevention of stroke (TRIPPS 2.0). Am J Cardiol 2013;111:1598–601. http://dx.doi.org/10.1016/j.amjcard.2013.01.331
413. Wiesel J, Arbesfeld B, Schechter D. Comparison of the Microlife blood pressure monitor with the Omron blood pressure monitor for detecting atrial fibrillation. Am J Cardiol 2014;114:1046–8. http://dx.doi.org/10.1016/j.amjcard.2014.07.016
414. Wiesel J, Arbesfeld BZ, Schechter D. Screening for atrial fibrillation using a blood pressure monitor: Omron vs microlife. Cardiology 2014;128:372.
415. Winkler S, Axmann C, Schannor B, Kim S, Leuthold T, Scherf M, et al. Diagnostic accuracy of a new detection algorithm for atrial fibrillation in cardiac telemonitoring with portable electrocardiogram devices. J Electrocardiol 2011;44:460–4. http://dx.doi.org/10.1016/j.jelectrocard.2011.01.011
416. Wyse DG. What is the best method of detecting atrial fibrillation in people aged 65 years and older? Nat Clin Pract Cardiovasc Med 2008;5:138–9. https://doi.org/10.1038/ncpcardio1063
417. Xu W, Tse HF, Chan FH, Fung PC, Lee KL, Lau CP. New Bayesian discriminator for detection of atrial tachyarrhythmias. Circulation 2002;105:1472–9. https://doi.org/10.1161/01.CIR.0000012349.14270.54
418. Yaghouby F, Ayatollahi A, Bahramali R, Yaghouby M, Alavi AH. Towards automatic detection of atrial fibrillation: a hybrid computational approach. Comput Biol Med 2010;40:919–30. http://dx.doi.org/10.1016/j.compbiomed.2010.10.004
419. Yiğit Z, Akdur H, Ersanli M, Okçün B, Güven O. The effect of exercise to P wave dispersion and its evaluation as a predictor of atrial fibrillation. Ann Noninvasive Electrocardiol 2003;8:308–12. https://doi.org/10.1046/j.1542-474X.2003.08408.x
420. Yung LTM, Brader S, Jordan D, Foley P. A comparison of mobile cardiac telemetry systems (MCT) with conventional cardiac monitoring for the investigation of common conditions suggestive of cardiac arrhythmias. Europace 2010;12:216.
421. Zenk BM, Bratton RL, Flipse TR, Page EE. Accuracy of detecting irregular cardiac rhythms via telemedicine. J Telemed Telecare 2004;10:55–8. http://dx.doi.org/10.1258/135763304322764211
422. Zhou X, Ding H, Ung B, Pickwell-MacPherson E, Zhang Y. Automatic online detection of atrial fibrillation based on symbolic dynamics and Shannon entropy. Biomed Eng Online 2014;13:18. http://dx.doi.org/10.1186/1475-925X-13-18.